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ABSTRACT

THE ROLE OF B-TYPE PHOSPHOLIPASES IN S. CEREVISIAE: FUNCTION,
REGULATION, AND PHYSIOLOGICAL RELEVANCE IN LIPID HOMEOSTASIS

By
Beth A. Surlow
August 2014

Dissertation supervised by Dr. Jana Patton-Vogt.
Membrane phospholipid synthesis and turnover is a continual process during normal cell
growth. The turnover of the glycerophospholipids by B-type phospholipases (PLBs) in
Saccharomyces cerevisiae results in the formation glycerophosphodiesters through a deacylation
reaction. Here, I address several aspects of the glycerophospholipid deacylation, transport, and
reutilization pathway in S. cerevisiae. First, I show the RAS GTPase-activating proteins, Ira1 and
Ira2, are required for utilization of the glycerophosphodiester – glycerophosphoinositol (GroPIns)
– as a phosphate source. Second, I demonstrate loss of the cell surface associated PLBs, Plb1-3,
and/or utilization of GroPIns causes actin cytoskeleton defects and an increased cell size. For the
third and major part of my dissertation, I identified a novel interaction between Ypk1 and Plb1.
Ypk1, the yeast homolog of the human serum- and glucocorticoid-induced kinase (Sgk1),
affects diverse cellular activities, including sphingolipid homeostasis. Here, I report that Ypk1 also
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impacts the turnover of the major phospholipid, phosphatidylcholine (PC). Pulse-chase
radiolabeling reveals that a ypk1∆ mutant exhibits increased Plb1-mediated PC deacylation and
glycerophosphocholine (GroPCho) production compared to wild type. Consistent with a link
between Ypk1 and Plb1, the levels of both Plb1 protein and PLB1 message are elevated in a ypk1∆
strain compared to WT yeast. Furthermore, I discovered that an increase in PLB1 expression also
occurs upon disruption to sphingolipid synthesis and is mediated by the Crz1 transcription factor.
Taken together, these findings suggest that sphingolipid synthesis is coordinated with PC turnover
to maintain optimal lipid homeostasis.
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Chapter 1 Introduction
1.1 Saccharomyces cerevisiae as a model organism
Saccharomyces cerevisiae (S. cerevisiae) the common budding yeast, is a well-studied
model eukaryote. Yeast was first used as an experimental organism in the early twentieth century
and has proven to be an asset in studying basic cellular processes (1). S. cerevisiae is a unicellular
fungus in the phylum Ascomycota that can exist stably in culture as a haploid or diploid. The
genome of S. cerevisiae has approximately 6,000 ORFs contained on 16 chromosomes. Several
characteristics of yeast have made it ideal to use in research. For example, the environmental
conditions can be controlled by using defined media, and altering the composition as needed. The
generation time for yeast is about 90 minutes, which allows for quick mass production.
Additionally, many yeast strains containing drug resistance, auxotrophic markers, and specific
mutations are readily available for use, including the yeast deletion set (2). A variety of other tools
are available for yeast researchers, including those associated with the Saccharomyces Genome
Database (SGD), where there is catalogued information on each gene (http://yeastgenome.org/).
Many cellular functions of yeast, including many aspects of lipid metabolism, are conserved
among higher eukaryotes, which make yeast a valuable model organism for studies of humans,
animals, and plants.
1.2 Major lipid classes in the S. cerevisiae plasma membrane
The primary structural components of the S. cerevisiae cell membrane include
glycerophospholipids, sphingolipids, and sterols, which are regulated by a variety of mechanisms
in order to maintain optimal lipid homeostasis (3). A structural illustration of an example from
each class of lipids is shown in Figure 1-1. The plasma membrane of the cell not only acts as a
boundary, but also mediates transport of molecules and acts as a platform for signaling pathways
1

(4,5). In response to cellular stress, the regulatory networks of these lipids must coordinately adapt
to maintain cell viability. Cells need to maintain the most favorable ratios of lipids in the plasma
membrane, as well as in the membranes of the different organelles (6). The mechanisms for lipid
trafficking between organelles, establishing and maintaining precise lipid compositions of specific
compartments, and changing of lipid environments in response to environmental signals are not
completely elucidated.

Glycerophospholipid
(Phosphatidylcholine, PC)

Sphingolipid
(Inositol phosphoceramide, IPC)

Sterol
(Ergosterol)

Figure 1-1. Structures of the major lipid classes in the S. cerevisiae plasma membrane.
Representative examples showing the basic structure of glycerophospholipids, sphingolipids, and sterols.
The head groups are circled in red, with choline and inositol for the glycerophospholipid and sphingolipid
respectively. Both the glycerophospholipid and sphingolipid have a phosphate group attached to the head
group, and the respective backbone, glycerol and ceramide. Structures were generated using the LIPID
MAPS structure database (7,8).

The major glycerolipids include the glycerophospholipids, – phosphatidylcholine (PC),
phosphatidylethanolamine

(PE),

phosphatidylserine

(PS),

phosphatidylinositol

(PI)

–

phosphatidylglycerol (PG), and cardiolipin (CL). Other phospholipid intermediates found in the
cell include phosphatidic acid (PA), diacylglycerol (DAG), triacylglycerol (TAG), CDP2

diacylglycerol

(CDP-DAG),

phosphatidyldiethanloamine

(PDME),

phosphatidylmonoethanloamine
phosphorylated

phosphoinositides

(PMME),
(PIPs),

and

lysophospholipids (LysoPL) (9). Structurally the glycerophospholipids are composed of a glycerol
backbone with two fatty acids attached by ester linkages, a phosphate group, and various head
groups. The primary fatty acids found in the glycerophospholipids are oleic, palmitoleic, palmitic
and stearic acids (5,9). The fatty acid and head groups both affect lipid packing in the membrane,
therefore influencing membrane fluidity. Significant progress has been made, and extensively
reviewed, in elucidating the aspects of glycerophospholipid metabolism, including gene-enzyme
relationships in biosynthetic pathways, localization of these processes, and regulation of synthesis
and turnover (9). The glycerophospholipids are the primary focus of this dissertation.
The classification of sphingolipids includes sphingosines, ceramides, sphingomyelin, and
phosphorylated or glycosylated derivatives of these metabolites (10,11). Sphingolipids have a
basic structure containing a ceramide moiety attached to a fatty acid by an amide linkage. The
three complex sphingolipids in S. cerevisiae are inositol phosphate ceramide (IPC), mannosylinositolphosphate-ceramide (MIPC), and mannosyl-diinositolphosphate-ceramide (M[IP]2C).
Greater than 90% of the cell’s complex sphingolipids are found in the plasma membrane (12). The
regulation of sphingolipid synthesis has largely been uncharacterized until very recently. The Orm
family of proteins were characterized and found to negatively regulate serine palmitoyl transferase,
the enzyme catalyzing the rate limiting step in sphingolipid biosynthesis (13) (Figure 4-5).
Understanding of sphingolipid metabolism will be important in Chapter 4 of this dissertation.
In S. cerevisiae, ergosterol is the most abundant sterol in the plasma membrane, which
serves a similar purpose to cholesterol, the main sterol lipid in higher eukaryotes. The sterols are
necessary to maintain membrane fluidity, protein function, and organelle differentiation (14). The
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research described here examined a potential connection to ergosterol metabolism, but was not
pursued in detail.
Together with membrane proteins, these lipids – glycerophospholipids, sphingolipids, and
ergosterol – make up the membranes of all cellular organelles, and the outer plasma membrane
boundary of the cell, which is greatly enriched in the complex sphingolipids and ergosterol. Lipid
asymmetry contributes to the physical properties of the membrane, with PE, PI, and PS enriched
in the intracellular leaflet, and with PC and sphingolipids primarily present in the extracellular
leaflet (5,15). Furthermore, enrichment of certain lipids and proteins into microdomains in the
membrane confers regulated functionality of the membrane as a platform for signaling cascades
(4,16). Considering the lipid ratios determine the functional characteristics of the membrane, it is
likely that crossover in regulation of lipid metabolism exists. Understanding the biosynthesis and
turnover of the glycerophospholipids and sphingolipids, in particular, will be essential for the
research described here.
1.3 Glycerophospholipid metabolism in yeast
S. cerevisiae has proven to be a powerful eukaryotic model for phospholipid metabolism
since many synthesis pathways are similar to those in mammalian cells (9,17-19). Phospholipids
are not only vital components of biological membranes, but many also act as signaling molecules
or precursors of signaling molecules that impinge upon a variety of cellular processes such as cell
growth and metabolism. Glycerophospholipids consist of two fatty acid chains bound via acyl
bonds to the SN1 and SN2 hydroxyl groups of a glycerol backbone. The primary
glycerophospholipids

found

in

S.

cerevisiae

include

phosphatidylcholine

(PC),

phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), all are
shown in Figure 1-2 (9,17). All of these major glycerophospholipids are derived from phosphatidic
acid (PA) and can be synthesized via the CDP-DAG pathway (20). Alternatively, PC and PE can
4

be synthesized via the Kennedy pathway, primarily when choline and ethanolamine are
supplemented in the media, although both pathways occur regardless of choline and ethanolamine
availability (9,17). The basic biochemical pathways for the synthesis of the major phospholipids
are summarized in Figure 1-3.

Figure 1-2. Structures of the major plasma membrane glycerophospholipids.
The structure shown at the top displays a generic glycerophospholipid with stearic and palmitic acid acyl
chains. The “X” can represent any of the head groups shown in the diagram to produce the corresponding
glycerophospholipid.

5

Figure 1-3. Synthesis pathways for the major phospholipids found in yeast.
The basic pathways for phospholipid synthesis and the gene products catalyzing the reactions are shown.
The major lipid species are shown in red boxes with yellow text. The glycerophosphodiesters are shown in
red boxes with blue text. The phosphorylated phosphoinositdes are shown in red boxes with black text.
Gene names shown in red are regulated by inositol and contain the UASINO element in their promoters. Other
gene products not regulated by inositol are shown in black. Metabolic intermediates are shown in black at
the end of arrows. Dotted line indicates several steps in the pathway were omitted. Gluc-6-P, glucose-6phosphate; Ins-1-P, inositol-1-phosphate; Gro-3-P, glycerol-3-phosphate; lyso-PA, lysophosphatidic acid;
PA, phosphatidic acid; CDP, cytidine diphosphate; DAG, diacylglycerol; PI, phosphatidylinositol; PS,
phosphatidylserine; PE, phosphatidylethanolamine; PMME, phosphatidylmonomethylethanolamine;
PMDE, phosphatidyldimethylethanolamine; PC, phosphatidylcholine; Cho, choline; Cho-P, choline
phosphate; Etn, ethanolamine; Etn-P, ethanolamine phosphate; PIP, phosphorylated phosphatidylinositol
phospholipids; GroPCho, glycerophosphocholine; GroPIns, glycerophosphoinositol.

The synthesis of these phospholipids is regulated by genetic and biochemical factors at the
transcriptional level, by mRNA stability, and post-translationally (9,17,20,21). Enzymatic activity
is additionally regulated by lipids, phospholipid precursors and products, and by covalent
modifications (20). Phospholipid biosynthetic genes are regulated by factors including nutrient
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availability, growth stage, pH, temperature, and by message stability (9,17). The promoters of
several genes in the CDP-DAG and Kennedy pathways contain the UASINO element (inositol
response upstream activating sequence), which is regulated by the transcription factors Ino2, Ino4,
and Opi1(20). The UASINO element, also known as the inositol/choline response element (ICRE),
contains a consensus binding site, 5’CATGTGAAT3’ (22),

for the Ino2/Ino4 heterodimer

complex, which activates transcription of several genes involved in glycerophospholipid synthesis
(9). Repression of transcription occurs via Opi1 binding to Ino2, hence preventing the Ino2/Ino4
complex from binding to the UASINO elements. (23,24).
These transcription factors are regulated by a series of mechanisms including the presence
or absence of inositol and choline (9). Several observations have supported the hypothesis
proposed by Carman and Henry that the mechanism by which the cells sense inositol, choline, and
other phospholipid precursors is through their effects on phospholipid synthesis (9). Furthermore,
evidence shows PA is the signaling lipid controlling the UASINO co-regulated genes. PA coregulates these genes by a mechanism in which Opi1 binds PA and Scs2, an integral ER membrane
protein, at the ER/nuclear membrane thereby preventing Opi1 translocation into the nucleus (25).
The binding affinity of Opi1 to PA is strongly affected by cellular pH, and in turn the ionization
state of PA, instead of the absolute abundance of PA (26). However, when PA levels are depressed,
such as when inositol is added to the medium, Opi1 can enter the nucleus and interact with Ino2
to prevent transcription (17,23).
PA content and UASINO containing genes are controlled, in part, by inositol (27) and zinc
(17). Inositol availability causes an increase in PI synthesis due to excess substrate availability,
which then results in depletion of the PA pool for synthesis of other phospholipids. Lower levels
of PA allow Opi1 repression of UASINO containing genes encoding enzymes in the CDP-DAG and
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Kennedy pathways causing an increase in PI and a decrease in PA, PS, and PC levels (20).
Depletion of zinc activates PI synthase resulting in decreased PA levels and repression of UASINO
containing genes involved in PE synthesis (21). As regulators of phospholipid synthesis, inositol
and zinc both regulate through PA levels. Briefly, PA levels are also regulated by the PA
phosphatase encoded by PAH1 and by DAG kinase encoded by DGK1 (28). The activity of several
phospholipid synthesis genes are additionally regulated by phosphorylation by PKA, PKC, and
casein kinase II (23). While PA has an important role in regulating glycerophospholipid synthesis
in S. cerevisiae, it is also implicated in multiple physiological processes in plant and animal cells,
with PA formation occurring in response to stress, such as pathogen infection or drought.
One UASINO containing gene commonly evaluated to assess overall misregulation of the
UASINO containing genes is INO1 (24). INO1 encodes inositol-3-phosphate synthase, which
converts glucose-6-phosphate to inositol-3-phosphate (29). INO1 is regulated by inositol and
choline at the transcriptional level. In the absence of inositol and choline, Ino2/Ino4 activates
transcription of INO1 through the UASINO element (24). Inositol auxotrophy and excess inositol
excretion can indicate misregulation of INO1 and other UASINO containing genes (23). For
example, ino2∆ and ino4∆ mutants are inositol auxotrophs, while opi1∆ mutants excrete excessive
inositol into the media. Testing for inositol auxotrophy and excess inositol secretion is commonly
employed to check for proper regulation of the phospholipid biosynthetic genes.
Synthesis of the primary glycerophospholipids mentioned thus far is clearly regulated at
various levels. These glycerophospholipids have biological importance as is, but are also available
for subsequent metabolism and modification. Multiple phosphorylated PI species (PIPs),
highlighted in Figure 1-4, are also present in S. cerevisiae. These PIPs are generated by the action
of kinases and/or phosphatases, which covalently modify three of the hydroxyl groups of the

8

inositol ring on PI. There are seven major PIPs derived from PI, each with a unique function and
localization:

phosphatidylinositol-4-phosphate

(PtdIns[4]P),

phosphatidylinositol-4,5-bis-

phosphate (PtdIns[4,5]P2), phosphatidylinositol-5-phosphate (PtdIns[5]P), phosphatidylinositol-3phosphate

(PtdIns[3]P),

phosphatidylinositol-3,4-bis-phosphate

phosphatidylinositol-3,5-bis-phosphate

(PtdIns[3,5]P2),

and

(PtdIns[3,4]P2),

phosphatidylinositol-3,4,5-

triphosphate (PtdIns[3,4,5]P3) (30). The PIPs found specifically in S. cerevisiae include,
PtdIns[3]P, PtdIns[4]P, PtdIns[3,5]P2, and PtdIns[4,5]P2 (31). Additionally, PtdIns[3,4,5]P3 has
been detected in the fission yeast Schizosaccharomyces pombe, but not in S. cerevisiae (31). The
PIPs each have distinct functions. The catabolism of PI and PC by the B-type phospholipase will
be the major focus of the study, but great interest lies in further examination of potential PIP
catabolism by the PLBs.

Figure 1-4. Phosphorylation sites of phosphatidylinositol.
Phosphatidylinositol can be phosphorylated at three of the hydroxyl groups on the inositol ring to produce
the phosphorylated phosphoinositides (PIPs). The hydrophilic inositol head group protrudes from biological
membranes making the hydroxyls in positions 3, 4, and 5 accessible to kinases and phosphatases found at
the membrane or in the cytosol.

1.4 Role and classification of phospholipases
During the course of normal cell growth, phospholipids are continually synthesized and
degraded in a regulated fashion. The catabolic reactions occur through the action of
phospholipases. Phospholipases are the enzymes that hydrolyze phospholipids to produce a variety
of metabolites, some of which have signaling functions, and some of which are shuttled back into
9

phospholipid synthesis or other metabolic pathways. Phospholipases, which have been identified
in both prokaryotes (32,33) and eukaryotes (34), are involved in a diverse range of processes
including membrane homeostasis, nutrient acquisition, interaction with host cells, and signaling
molecule production (35). In some organisms, phospholipases have a key role in virulence (36,37),
and are found in venoms (38,39).
Phospholipases are generally classified as types A (1 or 2), B, C, or D, depending on where
they cleave the phospholipids (Figure 1-5). The phospholipases A1 and A2 hydrolyze the SN1 and
SN2 fatty acid chains, respectively, producing a free fatty acid and a lysophospholipids
(phospholipids with only a single fatty acid). The B-type phospholipases (PLBs) have both A1 and
A2 activity meaning they can deacylate both the SN1 and SN2 acyl groups of glycerophospholipids
with minimal accumulation of lysophospholipids. Phospholipase C cleaves just before the
phosphate group producing diacylglycerol (DAG) and phosphate monoester (eg. inositolphosphate). Phospholipase D activity produces a free head group (eg. choline) and phosphatidic
acid. Lysophospholipase and transacylase enzymes also assist in catabolism and modification of
glycerophospholipids. Some fungal PLBs can have all three functions: phospholipase A1/A2
activity, lysophospholipase activity, and transacylase activity (35). Lysophospholipases deacylate
lysophospholipids, while transacylases act by transferring the acyl group from one
lysophospholipid to another. There are currently sixteen S. cerevisiae genes listed in the NCBI
Gene database with observed or putative phospholipase activity or domains (Appendix A 1).
PLA2 enzymes were the first phospholipases discovered and the superfamily has greatly
expanded the classification into six types, that each consist of one or more groups and subgroups:
1) secreted PLA2 (sPLA2) including Groups I, II, III, V, IX, X, XI, XII, XIII, and XIV each having
a His/Asp catalytic dyad, 2) cytoplasmic PLA2 (cPLA2) Group IV with a conserved catalytic
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Ser/Asp and critical Arg in proximity of the catalytic center, 3) calcium independent PLA2 (iPLA2)
Group VI also having a Ser/Asp catalytic site, 4) platelet activating factor acetylhydrolyase (PAFAH) Groups VII and VIII which have a conserved catalytic Ser/His/Asp, 5) lysosomal PLA2
(LPLA2) Group XV with a Ser/His/Asp catalytic site, and 6) adipose PLA2 (AdPLA2) Group XVI
containing a His/Cys catalytic site (40). The older classification system by the “Type” designation
has become more ambiguous with the continual discovery of new PLA2 enzymes, and with new
information obtained about the already identified PLA2s, such as the finding that most of the types
are all found in the cytoplasm, and several of the groups outside of the iPLA2 Type are also
independent of calcium. The group designations alone, which are based on the organism and
sequence homology, more accurately classify the differences between the PLA2s (41,42). Various
PLA2 enzymes exist in bacteria, fungi, and mammalian cells, which are all included as part of the
aforementioned classification system (35).

Figure 1-5. Phospholipase cleavage sites.
Generic phospholipid shown with the cleavage sites for the different phospholipases. Only phospholipase
B has the ability to hydrolyze both of the acyl groups.
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Many fungi have multiple PLB genes – S. cerevisiae has four known PLB genes and C.
albicans has five (35). In S. cerevisiae, the four genes encoding enzymes with phospholipase B
activity are PLB1, PLB2, PLB3, and NTE1 (43). PLB1, PLB2, and PLB3 have >60% identity at
the DNA level (44) and share a predicted catalytic center with conserved Arg/Ser/Asp (45). In
yeast, phospholipases help regulate many processes, including, but not limited to, growth,
nutritional/stress response, meiosis/mitosis cell cycle, and secretion (46).
1.5 Glycerophosphodiester production and transport in S. cerevisiae and higher eukaryotes
In S. cerevisiae, the deacylation of the glycerophospholipids via phospholipases of the Btype produce glycerophosphodiesters (GPXs) and free fatty acids (43). The B-type phospholipases
(PLBs) in S. cerevisiae are most similar to the mammalian cPLA2 Group IV phospholipases (4749). The deacylation of phosphatidylinositol (PI) and phosphatidylcholine (PC) in yeast produces
the intracellular and extracellular glycerophosphodiesters, glycerophosphoinositol (GroPIns) and
glycerophosphocholine (GroPCho), respectively (Figure 1-6). In mammalian cells, PLA1/2 activity
followed by lysophospholipase activity will release arachadonic acid, lysophosphatidylinositol
(LysoPI), and the glycerophosphoinositols (49-51). Bacteria (52,53), mammals including humans
(54-57), and fungi (35,36) all possess enzymes with PLB activity. A human homologue of PLB
was first identified in the epidermis, suggesting a function involving hydrolysis of lipids for use
as components of the epidermal barrier (49). A PLB precursor has also been identified in human
neutrophils, which has the ability to deacylate PC, PI, PE, and their lysophospholipids, suggesting
a role in defense against microbes or involvement in inflammation (49,58).
Glycerophosphodiesters can also be formed by catabolism of the phosphorylated
phosphoinositols

(PIPs)

to

produce

the

collectively

termed,

glycerophosphoinositol

glycerophosphodiesters (GroPIPs). The GroPIPs are water-soluble metabolites initially thought to
be byproducts of PIP metabolism. However, evidence suggests these metabolites have their own
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functions and metabolism (49,51). In mammalian cells, PLA2IVα produces GroPIns and
GroPI[4]P via its dual phospholipase and lysophospholipase activity on PI and PtdIns[4]P
respectively (49). PLA2IVα activity is suggested to be regulated by calcium, phosphorylation,
PtdIns[4,5]P2 binding, and hormonal stimulation (40,49). Production of GroPIns and GroPI[4]P
have been reported in many cell types upon different types of stimulation, such as by calcium or
hormones (50). A few examples include GroPIns production upon stimulation of platelets,
macrophages, neutrophils, thyroid cells, kidney slices, and brain slices. GroPI[4]P production has
been observed in cell types such as fibroblasts, thyroid cells, and hepatocytes.

Figure 1-6. Deacylation Reaction.
The glycerophospholipid, phosphatidylcholine (PC), is deacylated via the action of a B-type phospholipase
enzyme to produce the glycerophosphodiester, glycerophosphocholine (GroPCho) and two free fatty acids.

The deacylation of the PIPs in yeast is also a regulated process that is influenced by several
conditions. In S. cerevisiae, GroPIns, GroPI[4]P and GroPI[4,5]P2 release has been observed upon
stimulation by glucose (59). Importantly, no studies have addressed the role of Plb1-3 in GroPI[4]P
and GroPI[4,5]P2 release, although published literature states the PLBs also act on the PIPs to
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produce GroPIPs (44,45). This extracellular release of the GroPIPs occurs in both yeast and
mammalian cells (49,60). Upon release in mammalian cells, the GroPIPs may be further
metabolized by extracellular phosphodiesterases, act as paracrine or autocrine signals, or can be
transported back into the cell (49).
The glycerophosphodiesters are hydrophilic and cannot enter the cell without the action of
a transporter. The glycerophosphodiester transporter, Git1, was first discovered in yeast when
GroPIns was observed to be secreted and taken back up (61). The human protein with the highest
identity to Git1 was later identified as Glut2 (62). Glut2 mediates uptake of GroPIns and is
primarily expressed in cells of the liver, kidney, and small intestine (49). GroPIns is able to get
into cells not expressing Glut2, indicating there are likely other unidentified GroPIns transporters
in mammalian cells (49).
In S. cerevisiae, both GroPIns and GroPCho can be transported into the cell via the
permease encoded by GIT1. Once inside the cell, GroPIns and GroPCho are metabolized. In fact,
exogenous GroPIns and GroPCho can individually be provided as the sole phosphate source for
the cells (63,64). GroPCho is broken down into choline and glycerol-3-phosphate via the
glycerophosphodiester phosphodiesterase, Gde1 (65,66). The enzyme facilitating the catabolism
of GroPIns and the subsequent products is currently unknown. The biochemical pathways specific
to GroPIns and GroPCho in S. cerevisiae are shown in Figure 1-7. The deacylated
glycerophosphoinositide (GroPIPs) derivatives exit and enter mammalian cells as well (50,67,68).
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Figure 1-7. Metabolic pathways for GroPIns and GroPCho in S. cerevisiae.
GroPIns and GroPCho metabolism and transport are shown with the corresponding genes that encode the
enzymes required for the reactions to take place. Git1 transports GroPIns and GroPCho into the cell.

1.6 The B-type Phospholipases in S. cerevisiae
Some information about substrate preferences and factors affecting each of the PLB gene
products is available through gene deletion and overexpression studies. Plb1 primarily deacylates
PC producing GroPCho, and less robustly produces GroPEtn from PE (69). Plb2 is responsible for
exogenous phospholipid hydrolysis (45). Plb3, which only uses PtdIns and PtdSer as substrates, is
thought to be mainly responsible for extracellular GroPIns production with Plb1 having some
additional influence (45). Plb1, Plb2, and Plb3 have phospholipase B, lysophospholipase, and
lysophospholipid acyltransferase (LPAT) activities (45,46,69). The other enzyme with
phospholipase B activity in S. cerevisiae, Nte1, controls internal GroPCho production and has been
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suggested to be localized to the endoplasmic reticulum (70). At a lower efficiency Plb1 and Plb2
can hydrolyze PA and PtdIns[4,5]P2 (44).
Biochemical studies have predicted Plb1 and Plb3 localization at the plasma membrane
and periplasmic space in stationary phase S. cerevisiae cells (43,45,69). In addition to localization
in the plasma membrane and periplasmic space, Plb2 is predicted to be found in the supernatant
(43,45). However, large-scale microscopic datasets employing fluorescent tags fused to the Cterminal end and expressed under control of their endogenous promoters, YPL+ (71,72) and
YeastGFP (73-75), and a study utilizing C-terminal fusions to an epitope tag with the target genes
expressed under control of the GAL promoter, Organelle DB (76), contain no data or inconclusive
data for Plb1, Plb2, and Plb3 localization, as reported on SGD. In addition, a localization screen
of proteins involved in lipid metabolism, in which Plb1 was C-terminally tagged and expressed
under the TEF promoter, showed ER and vesicle localization, but no PM localization, and the
medium

was

not

analyzed

(77).

Furthermore,

Plb1

and

Plb3

have

predicted

glycosylphosphatidylinositol (GPI) – anchor attachment sites (78). Interestingly, recent evidence
in addition to the data presented in Chapter 4, suggests Plb1 may have an intracellular role.
Analysis of the enzyme kinetics for the B-type phospholipases, and all phospholipases, is
complex given that the enzymes act on individual lipids that are aggregated together to form
micelles, vesicles, and membrane bilayers at the lipid-water interface (40). Frequently, a “surface
dilution kinetic model” is employed to study many enzymes in lipid metabolism in vitro, in which
activity is measured in the presence of cell-free mixed micelles containing lipids and a detergent
(79). The affinity for different substrates of the B-type phospholipases in vivo mentioned above is
different from the primary substrates observed in vitro (44). Furthermore, in vitro experiments
have shown pH, and the presence or absence of various cations, Ca+2, Mg+2, Fe+3, and Al+3, affect
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the activity of Plb1, Plb2, and Plb3 (44). Of particular interest, at pH = 2.5 the presence of any of
the listed cations caused decreased activity of Plb1, but at pH = 5.5 Plb1 activity was increased by
the presence of the cations. In vivo Plb1-mediated GroPCho production increased with increasing
pH from 3.5 to 7.5, contrary to the in vitro observations that increasing pH resulted in decreased
Plb1 activity (44). Importantly, Plb1 activity can clearly be affected by pH and cations.
1.7 Glycerophosphodiesterase hydrolysis of the glycerophosphodiesters
A number of glycerophosphodiesterases (GDEs) that catalyze the breakdown of the
glycerophosphodiesters have been characterized in bacteria, fungi, plants, and animals (51). In S.
cerevisiae, the glycerophosphodiesterase Gde1 hydrolyzes GroPCho to choline and glycerol-3phosphate, but the enzyme facilitating breakdown of GroPIns is unknown (65,66). In mammalian
cells, seven different GDEs (GDE1 – 7) have been identified each with specific substrate
specificity, cellular localization, and tissue specificity (51). The mammalian GDE enzymes are
relatively newly characterized proteins, and unlike bacterial GDE enzymes, can hydrolyze
substrates other than the glycerophosphodiesters, including GPI anchors (51). Both mammalian
Gde1 and Gde3 prefer GroPIns over GroPCho, but they hydrolyze different bonds. Gde1 activity
produces inositol and glycerol phosphate, while Gde3 acts like a PLC, producing glycerol and
inositol-1-P (49,51). All but one of the mammalian GDEs are predicted to be membrane bound, so
the GPXs would need to reach the plasma membrane for further catabolism (49) supporting the
role of PLB or PLA activity at the plasma membrane.
1.8 Summary of Background and Significance
The PLBs deacylate phospholipids, thereby changing the phospholipid composition of the
cell membrane. Several studies have shown that certain signaling pathways, protein activities, and
cytoskeletal elements require specific membrane phospholipid composition for proper functioning.
In addition, the PLB products, the glycerophosphodiesters, have been shown to elicit physiological
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effects in mammalian cells, including those involved in cytoskeletal function and cell morphology.
A more thorough examination of PLB function and regulation in the yeast S. cerevisiae, as
described here, provides novel evidence for how phospholipase B activity impacts cellular
physiology.
The overall goal of my project was to further elucidate the physiological functions and
regulation of the B-type phospholipases (PLBs). My central hypothesis was that the PLBs are
important for membrane homeostasis and cellular functions under certain environmental
conditions. The specific objectives of my work as detailed in the following three chapters were as
follows: 1) Determine how alterations in the RAS/cAMP signal transduction pathway affect PLB1,
PLB2, and PLB3 gene response, 2) Examine phenotypes associated with deletion of one or more
of the PLB genes and identify potential genetic interactions that could contribute to the elucidation
of the PLB function, and 3) Elucidate the mechanism by which Ypk1 regulates Plb1 activity.
Objectives 1 and 2 were initiated for the intended completion of the M.S. degree, but instead led
into my transition to the Ph.D. program, at which time I began the major project for my Ph.D.
work, Objective 3. Each of these objectives will be discussed individually in Chapters 2, 3, and 4
respectively, with Chapter 4 serving as the majority of my Ph.D. work. Together, the data provided
here furthers our understanding of the role and regulation of the PLBs.
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Chapter 2 Neurofibromin Homologs Ira1 and
Ira2 affect glycerophosphoinositol Production
and Transport in Saccharomyces cerevisiae
Running Title: Glycerophosphoinositol metabolism
Reprinted from Eukaryotic Cell, Vol. 8 No. 12, pages 1808-1811.
Bishop, A. C.*, Surlow, B.A.*, Anand, P., Hofer, K., Henkel, M., Patton-Vogt, J.
"Neurofibromin homologs Ira1 and Ira2 affect glycerophosphoinositol production and transport
in Saccharomyces cerevisiae." Copyright (2009) with permission from the American Society of
Microbiology.
*A.C. Bishop and B.A. Surlow contributed equally to this work.
Chapter 3 Attributions:
Beth Surlow, I completed the growth studies shown in Figure 1 and the real time qRT-PCR of
the PLB genes in the IRA mutant strains (data not shown in publication). Additional experiments
I completed pertaining to this project, but excluded from final submission of the publication are
included in the Supplement to Chapter 2.
Andrew Bishop, a graduate student in the Patton Vogt lab, completed the GroPIns transport and
production experiments shown in Figure 2.
Puneet Anand, a Masters student in the Patton-Vogt lab, performed the initial screen of the
yeast knockout collection to identify strains bearing compromised growth when given GroPIns
as the sole phosphate source.
Katherine Hofer, an undergraduate in the Patton Vogt lab performed anion exchange
chromatography for separation of inositol containing compounds in Figure 2.
Abstract
Saccharomyces cerevisiae produces extracellular glycerophosphoinositol through
phospholipase-mediated turnover of phosphatidylinositol and transports glycerophosphoinositol
into the cell upon nutrient limitation. A screening identified the RAS GTPase-activating proteins
Ira1 and Ira2 as required for utilization of glycerophosphoinositol as the sole phosphate source,
but the RAS/cyclic AMP pathway does not appear to be involved in the growth phenotype. Ira1
and Ira2 affect both the production and transport of glycerophosphoinositol.
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2.1 Introduction
Membrane phospholipids are continually synthesized and degraded as cells grow and
respond to environmental conditions. A major pathway of phosphatidylinositol (PI) turnover in
Saccharomyces cerevisiae is its deacylation to produce extracellular glycerophosphoinositol
(GroPIns) (60). Plb3, an enzyme with phospholipase B (PLB)/lysophospholipase activity, is
thought to be primarily responsible for the production of extracellular GroPIns, with Plb1 playing
a lesser role (44,45,69). GroPIns is transported into the cell by the Git1 permease (61). GIT1
expression is upregulated by phosphate limitation and inositol limitation. In fact, GroPIns can act
as the cell’s sole source of both inositol (61) and phosphate (63).
A screening for gene products involved in the process by which GroPIns enters the cellular
metabolism identified Ira1 and Ira2, yeast homologs of the mammalian protein neurofibromin.
Alterations in NF1, the gene encoding neurofibromin, are associated with the pathogenesis of
neurofibromatosis type 1, an autosomal dominant genetic disease (80-82). Ira1 and Ira2 and
neurofibromin function as RAS GTPase-activating proteins (RAS GAPs). S. cerevisiae Ras1 and
Ras2 activate adenylate cyclase to modulate cyclic AMP (cAMP) levels. The binding of cAMP to
the regulatory subunits of protein kinase A (Bcy1) results in dissociation and activation of the
catalytic subunits (Tpk1 to Tpk3). Ira1 and Ira2 inactivate RAS and thereby downregulate the
pathway (83,84). Hydrolysis of cAMP by the phosphodiesterases encoded by PDE1 and PDE2
also downregulates the pathway (85-87). The RAS/cAMP pathway responds to nutrient signals to
modulate fundamental cellular processes, including stress resistance, metabolism, and cell
proliferation (85,87,88).
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2.2 Results and Discussion
2.2.1 Identification of IRA genes as affecting GroPIns metabolism.
To identify genes involved in the metabolic process by which GroPIns is used as a
phosphate source, we screened the MATα viable yeast knockout collection (Research Genetics) for
strains displaying compromised growth when GroPIns rather than low Pi was supplied as the
phosphate source. Synthetic complete medium, high-Pi (10 mM KH2PO4) medium, low-Pi (0.2
mM KH2PO4) medium, and GroPIns+ (70 µM) medium were made as described previously (64).
Mutants were transferred by hand pinner from a master plate to a 96-well plate containing low-Pi
medium and allowed to grow at 30°C for 3 days. From low-Pi medium, cell inocula were
transferred to plates containing GroPIns+ medium. Growth was monitored at 595 nm after 4 days
of incubation at 30°C. The ratio of absorbance in low-Pi medium to absorbance in GroPIns+
medium was determined. This screening was performed twice. Mutants with a value of 3 or greater
for the ratio of absorbance in low-Pi medium to absorbance in GroPIns+ medium were subjected
to a second screening by the monitoring of their growth in test tubes. As expected, the GIT1 gene
was required for growth, and no other mutant displayed a complete growth abatement phenotype
(Figure 2-1 A). In particular, we did not identify a gene likely to encode a
glycerophosphodiesterase responsible for GroPIns catabolism. A likely explanation for this result
is that multiple gene products are involved in the mechanism(s) by which GroPIns enters cellular
metabolism. However, a number of strains exhibited a slow-growth phenotype, one of which was
the ira2∆ mutant (Figure 2-1 A). To confirm the validity of this result, we analyzed growth on
GroPIns in strains of the unrelated ∑1278b background (gifts from M. Cardenas, Duke
University), and found that not only the ira2∆ mutant but also the ira1∆ mutant and the ira1∆ira2∆
double mutant (Table 1) exhibited greatly reduced growth on GroPIns (Figure 2-1 B). The ira1∆
mutant was not present in the deletion set screened initially.
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Table 2.1 S. cerevisiae strains used in this study (Chapter 2)

To probe the role of the RAS/cAMP in GroPIns metabolism, we analyzed other strains
bearing alterations in the pathway. Interestingly, a pde2∆ mutant that, like the ira2∆ mutant,
exhibits increased cAMP levels (89) was not defective for growth on GroPIns. Similarly, a strain
bearing a plasmid-borne hyperactive allele of RAS2, RAS2-V19 (a gift from P. Herman, Ohio State
University) (90-92), was not defective for growth on GroPIns (Figure 2-1 A). Thus, upregulation
of the RAS/cAMP pathway may not be the primary reason for the growth defect seen in the
absence of Ira1 or Ira2. Not surprisingly, ras1∆ and ras2∆ mutants, expected to downregulate the
RAS/cAMP pathway, were not defective for growth on GroPIns (data not shown).
A trivial explanation for the inability of strains bearing mutations in the IRA genes to utilize
GroPIns as a phosphate source is that the cells are less robust than WT cells and die before they
are able to induce the metabolism required to utilize GroPIns. To test this, we compared the
survival of the WT and an ira1∆ira2∆ mutant upon phosphate starvation and found no difference
between the two strains (data not shown).
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Figure 2-1. Ira1 and Ira2 are required for optimal growth of cells using GroPIns as a
phosphate source.
Strains in the BY4742 (A) or ∑1278b (B) background were grown overnight in low-Pi medium. Cells were
transferred to low-Pi or GroPIns+ medium (A600 ≈ 0.005). Absorbance was recorded after 48 h of growth at
30°C. WT cells transformed with empty vector pRS415 (vector) or plasmid pPHY453, containing the
hyperactive RAS2 allele, RAS2-Val19 (RAS2V19), were also assayed (A). Readings are means ± standard
errors of the means of results of at least two independent experiments.

2.2.2An ira1∆ira2∆ mutant exhibits altered GroPIns transport activity.
To determine the cause of the defect in GroPIns utilization that occurs upon deletion of
IRA1 or IRA2, we measured GroPIns transport activity (63) under low-Pi conditions. In cells
harboring single-deletion mutations, GroPIns transport was similar to that of the WT strain or only
slightly reduced (Figure 2-2 A). However, the simultaneous deletion of IRA1 and IRA2 resulted in
a clear reduction in activity. These results do not explain the growth defects seen in the singledeletion mutants, but they do indicate a role for Ira1 or Ira2 in regulating Git1. A complete
understanding of the nature of the regulation of GroPIns transport by Ira1 or Ira2 will be the focus
of future studies.
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Figure 2-2. Ira1 and Ira2 affect GroPIns transport activity and GroPIns production.
(A) Cells grown to log phase in low-Pi medium were assayed for GroPIns transport activity. Data represent
means ± standard errors of the means of results of two independent experiments performed in duplicate.
(B) Cells pre-labeled with [3H]-inositol were re-inoculated into fresh high-Pi medium, and the amount of
extracellular GroPIns was determined following 22 h of growth. Data are means ± standard errors of the
means of results of at least three independent experiments and are reported as the percentage of total [3H]inositol label found as extracellular GroPIns normalized for culture density.

2.2.3 Deletion of IRA1 or IRA2 increases the extracellular accumulation of GroPIns.
We next monitored the effect of Ira1 or Ira2 upon extracellular production of GroPIns via
PI deacylation. Cells were grown overnight in medium containing 3 µCi/ml of [2-3H]-inositol.
Cells were harvested, washed, and reinoculated to an A600 of 0.2 in high-Pi medium, the condition
under which extracellular GroPIns accumulates (61). At various times, aliquots of the cultures
were centrifuged, and the inositol compounds in the supernatant were separated (93). The ira1∆,
ira2∆, and ira1∆ira2∆ mutants accumulated roughly twice as much extracellular GroPIns as the
WT strain (Figure 2-2 B) upon entrance to stationary phase. The lack of an additive effect upon
GroPIns formation in the double mutant compared to formation in the single mutants may be
explained by substrate availability. In other words, there may be a limited amount of plasma
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membrane-associated PI available for PLB-mediated turnover. Whereas an ira1∆ira2∆ double
mutant exhibits an increase in PLB1 and PLB3 transcript levels as measured by real-time reverse
transcriptase PCR (data not shown, Supplemental Figure 2-3 S), no such increase was detectable
in the ira1∆ or ira2∆ mutant. Thus, Ira1 or Ira2 regulation of the PLB activity leading to GroPIns
formation likely occurs at multiple levels and will be the focus of future studies. Another
explanation is that yet another, uncharacterized, phospholipase exists for the formation of GroPIns
in the absence of Ira1 or Ira2. Importantly, GroPIns transport does not occur under the growth
conditions of the experiment (high Pi), so diminished transport cannot explain the increased
accumulation of GroPIns in the absence of Ira1 or Ira2.
In summary, this study indicates a role for Ira1 and Ira2 in regulation of both the production
of extracellular GroPIns and its transport into the cell. In addition, we show that Ira1 and Ira2 are
required for the utilization of GroPIns as a phosphate source under conditions in which transport
of GroPIns into the cell is normal. However, we were unable to show a linkage between
hyperactivation of the RAS/cAMP pathway, which occurs upon deletion of IRA1 or IRA2, and the
growth phenotype. Future studies will focus on determining the mechanism(s) for the growth
disturbance, including whether it involves the RAS/cAMP pathway or other, less defined functions
of Ira and Ira2. Growth is a multifactorial process, and a combination of disturbances, some
involving heightened signaling through the RAS/cAMP pathway and some not, may contribute to
alterations in the cell’s ability to utilize GroPIns as a phosphate source. Ira1 and Ira2 are large
proteins, each over 3,000 amino acids. The RAS GAP-related domain of each protein is contained
within a few hundred amino acids, and C-terminal regions of approximately 200 amino acids bind
to Gpb1 or Gpb2 and are important for protein stability (94). In addition, yeast Ira1 and Ira2
proteins and the human neurofibromin type 1 protein all contain bipartite phospholipid binding
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modules consisting of a Sec14 homologous segment and a pleckstrin homology-like domain (95).
Both in vitro phospholipid binding and lipid exchange activity have been documented for
neurofibromin (96), suggesting that Ira1 and Ira2 may have similar activities. Indeed, Ira1 appears
to play a membrane-anchoring role for adenylate cyclase in addition to its role as a RAS GAP (97).
It is tempting to speculate that Ira1 or Ira2 might also play a role in the membrane association or
activation of an enzyme or enzymes responsible for the metabolism of internalized GroPIns. A test
of that hypothesis awaits the identification of the gene products involved in the process by which
GroPIns enters cellular metabolism.
This work was supported by National Institutes of Health grant GM59817 to J.P.-V. We
thank M. Cardenas for the gift of strains and P. Herman for the gift of plasmids. We thank Lindsay
Chromiak and David Ekpin for technical assistance.
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2.3 Supplement to Chapter 2
The experiments described here were completed as part of the project described in the
Chapter 2 manuscript, but were excluded from the publication. The purpose of these supplemental
studies was to examine PLB1-3 and INO1 transcriptional expression in response to alterations in
the Ras/cAMP pathway
2.3.1 Experimental Procedures
Strains, plasmids, and growth conditions. The S. cerevisiae strains used in this study are
shown in Table 2.1. Strains were grown aerobically with shaking at 30ºC. Turbidity was
monitored by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo Spectronic
spectrophotometer. Media used for this study included rich yeast extract peptone dextrose (YEPD)
media, or synthetic complete yeast nitrogen base (YNB) media made as described previously, but
containing 2% glucose (93). To control media phosphate concentration, KH2PO4 (1 g/L) was
excluded from the synthetic mix and replaced with KCl (1 g/L). KH2PO4 was added back at a
concentration of 10 mM (high) or 200 µM (low) as indicated. YNB containing 75 µM inositol (I+)
or lacking inositol (I-) was used as noted.
The plasmids pRS416 (JVE288) and pJR1040-RASVal19 (JVE290) were kindly provided by
Paul Herman (90) (The Ohio State University). Plasmids pBH315-GIT1-lacZ (JVE294) and
pJH359-INO1/CYC1/lacZ (98) were available or made previously in the lab. Transformation of
plasmids into yeast strains was performed using standard lithium acetate chemical transformation.
β-galactosidase assays. Gene promoter activity was measured as a function of β-galactosidase
(β-gal) activity using either the Pierce β-galactosidase kit per the manufacturer’s instructions or
using the lab β-gal protocol. Cells were grown to late log phase in YNB medium lacking the
specified amino acid for selection, harvested, and an aliquot was assayed for β-gal activity. Briefly,
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using the Pierce kit, 350 µL of working solution (50:50, 2X β-gal assay buffer: Y-PER) was added
to 350 µL of culture to start the assay and incubated at room temperature for 6.5 minutes. β-gal
stop solution (300 µL) was added, solution agitated with a Vortex mixer, and centrifuged for 30s
at 13,000 x g. Supernatant absorbance was measured at 420 nm and used to calculate β-gal activity
([1000 x A420nm]/[time in minutes x Volume in mL x OD600 at harvest]). For the lab procedure, 10
ODUs (optical density units) of cells were harvested and resuspended by Vortex agitation in 150
µL of Z buffer, 50 µL chloroform, and 20 µL of 0.1% SDS. 0.7 mL of ONPG (1.2 mg/mL) was
added to start the reaction and incubated at room temperature for 10 minutes. The reaction was
stopped with 0.5 mL of 1M Na2CO3 and centrifuged for 2 minutes. The absorbance of the
supernatant was measured at 420 nm and used to calculate β-gal activity (A420nm x 1000 x (1/time
in minutes)).
RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in
YNB medium containing 75 µM inositol under the conditions specified in the text. RNA was
extracted using a hot phenol-chloroform extraction (99). A 7 µg sample of RNA was DNase treated
with 2 units of DNase at 37ºC for 30 minutes using the TURBO DNA-free™ Kit (Applied
Biosystems) per the manufacturer. Message abundance was quantified by quantitative reverse
transcriptase PCR (qRT-PCR) using the Verso™ SYBR® Green 1-Step QRT-PCR ROX Kit
(Thermo Scientific) on the Applied Biosystems StepOnePlus Real Time PCR System. The
primers used are shown in Table 3.2. Standard curves for each primer pair were optimized to
determine acceptable primer concentration (70-100 nM) and template concentrations (15-25 ng/25
µL reaction). Reverse transcription was carried out at 50C for 15 min followed by 95C for 15
min for RT inactivation and polymerase activation. Amplification parameters were 40 cycles at
95C 15s, 54.5C 30s, and 72C 40s. Primer specificity was verified by melt curve analysis and
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visualization of amplicons by gel electrophoresis. Primer sets did not produce amplicons when
RNA from the respective deletion strains was used as template. No template control (NTC) and
minus reverse transcriptase (-RT) reactions were performed to verify there was no genomic DNA
contamination in the RNA samples and/or the reagents. RNA from at least three independent
cultures of all strains was analyzed in triplicate reactions per primer set. Data was normalized to
the endogenous control gene, SNR17, and analyzed using the comparative ∆CT approach
(100,101).
2.3.2 Results and Discussion
An ira1∆ira2∆ mutant exhibits altered PLB1-3 transcript levels.
The B-type phospholipase encoded by PLB3 is primarily responsible for the production of
GroPIns via PI deacylation, with Plb1 having some contribution (44). To determine if
transcriptional regulation of the PLB genes is responsible for the increase in GroPIns production
observed upon deletion of IRA1 and IRA2, real-time qRT-PCR was performed. The transcript
level of PLB2 was also monitored. Deletion of both IRA1 and IRA2 resulted in an increase in
PLB1 and PLB3 message (Figure 2-3 S). However, deletion of IRA1 or IRA2 individually had little
or no effect on PLB1 transcript levels and actually decreased PLB3 transcript levels. Hence, these
results do not support a model for increased PLB gene expression causing the increased GroPIns
production occurring upon deletion of IRA2 (Figure 2-2 B), but do indicate that deletion of both
IRA1 and IRA2 affects PLB1 and PLB3 message levels. With regard to PLB2, there was a clear
decrease in transcript levels in the ira1∆, ira2∆, and ira1∆ ira2∆ mutants (Figure 2-3 S).
INO1 expression is altered in the IRA1 and IRA2 mutants.
During the course of the transport experiments, we discovered that ira1∆ira2∆ mutants are
inositol auxotrophs. Inositol auxotrophy is typically the result of misregulation of INO1, the gene
29

encoding inositol-3-phosphate synthase (Figure 1-3), which is the rate-limiting step in inositol
biosynthesis (29). In a WT strain, INO1 is derepressed in cells grown in inositol-free medium, and
repressed in cells grown in inositol containing medium. We hypothesized the inositol auxotrophy
in the IRA mutants is due to misregulation of the INO1 gene. INO1 expression was monitored in
response to phosphate and inositol concentrations by transforming strains with a reporter construct,
in which the INO1 promoter is fused to lacZ (98). Because the ira1∆ira2∆ mutant cannot grow in
the absence of inositol, INO1 expression was monitored in the presence of 10M inositol, a
concentration that supports growth and only partially represses INO1 expression in a WT strain.
Deletion of either IRA1 or IRA2 reduces INO1 expression, and the deletion of both simultaneously
increases the effect (Figure 2-4 S). Also noteworthy is that INO1 expression, in general, is reduced
under low phosphate conditions. Importantly, the reduced INO1 expression of the ira1∆, ira2∆
and ira1∆ira2∆ double mutants cannot explain the growth defect observed when GroPIns was
supplied as a phosphate source, as the growth experiments shown in Figure 2-1 were performed in
the presence of inositol.
Upregulation of the Ras/cAMP pathway with the RasV19 allele results in inositol auxotrophy
Because prior experiments in the lab showed ira1,2∆ is an inositol auxotroph, and ira1∆,
ira2∆, and ira1,2∆ have defective growth on GroPIns we hypothesized that upregulation of the
Ras/cAMP pathway by introduction of a constitutively active form of RAS, RasVal19, may have a
similar affect (90). A strain bearing a hyperactive allele of RAS2, RAS2V19 (91) exhibited moderate
inositol auxotrophy (Figure 2-5 S), suggesting that upregulation of the RAS/cAMP pathway is
involved in mediating the inositol auxotrophy phenotype.
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Figure 2-3 S. PLB1 and PLB3 message levels are elevated in the ira1ira2 double mutant
but not in the single deletion strains.
Relative message abundance of PLB1, PLB2, and PLB3 in WT (JPV 569), ira1∆ (JPV 573), ira2∆ (JPV
574), and ira1∆ira2∆ (JPV 575) (∑1278b background) grown in YNB highPi medium to log phase (OD600
≈ 0.7) at 30ºC. Total RNA was extracted from cells and transcript levels were analyzed by real-time qRTPCR using the comparative ∆CT method. Data were normalized to the amount of the endogenous control
mRNA, SNR17, and expressed relative to the value in WT cells. Values represent the mean ± S.E. of at
least 3 individual cultures each assayed in triplicate.

Figure 2-4 S. Deletion of IRA1 or IRA2 decreases INO1 promoter-driven ß-galactosidase
activity.
WT (JPV 467), ira1 (JPV 573), ira2 (JPV 574), and ira1,2 (JPV 575) were transformed with the
plasmid pJH359-INO1/CYC1/lacZ (JVE3) and grown to late log phase (OD600 ≈ 0.8-1.0) in YNB –URA
media with the indicated phosphate and inositol concentrations. Cells were harvested and assayed using the
Pierce β-gal assay kit. Data represent the mean ± S.E. of three individual transformants in each strain
assayed in duplicate.
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Figure 2-5 S. Expression of the hyperactive RAS2V19 allele results in inositol auxotrophy.
WT (JPV 569) transformed with empty vector (pRS416 empty, JVE289) or plasmid pJR1040 containing a
hyperactive RAS2 allele (RAS2V19) (JVE291) were spotted onto YNB – URA synthetic medium containing
(I+) or lacking (I-) inositol. 5 l of cells normalized to A600=0.5 were spotted in a series of four 10-fold
dilutions.

Lack of inositol increases GIT1 expression in the WT and ira1 strains
Clearly Ira1 and Ira2 affect inositol biosynthesis and GroPIns transport. Since GIT1
expression is upregulated by phosphate starvation (102) and by inositol limitation in a WT strain
(Figure 2-6 S), GIT1 expression upon inositol limitation in the IRA mutants was monitored using
a plasmid with β–gal activity driven by the GIT1 promoter. Lack of inositol increases GIT1
expression similar to WT in the ira1 strain, while GIT1 expression in the ira2 strain is
unchanged by presence or absence of inositol (Figure 2-6 S). Although there is increased GroPIns
accumulation in the IRA mutants as compared to the WT (Figure 2-2), this cannot be explained by
the potential lack of GroPIns transport due to a decrease in GIT1 expression because in I+
conditions the mutants and WT have similar GIT1 expression. Furthermore, the transport
experiments were performed in abundant phosphate conditions in which Git1 activity is turned off
(102).
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Figure 2-6 S. GIT1 expression is decreased in WT and ira1∆ in media containing inositol.
WT (JPV 569), ira1∆ (JPV 573), and ira2∆ (JPV 574) were transformed with GIT1-lacZ containing plasmid
(JVE 294). At least three individual transformants were grown to late log phase at 30°C in -URA 200µM
phosphate +/- inositol media and assayed for β-gal activity using the lab protocol. Data are means ± S.E.

2.3.3 Conclusions
A relationship between Ira1/2 and inositol biosynthesis was uncovered by the finding that
the ira1∆ira2∆ mutant is an inositol auxotroph. Misregulation of INO1, which is normally
derepressed in the absence of inositol, is typically the cause of inositol auxotrophy. Indeed, INO1driven -galactosidase activity was decreased upon deletion of IRA1 or IRA2. The fact that a
hyperactive RAS2 allele exhibited moderate inositol auxotrophy suggests that this phenotype,
unlike the growth phenotype, is attributable to hyperactivation of the RAS/cAMP pathway.
In addition to affecting GroPIns transport and inositol biosynthesis, our results indicate that
Ira1/2 affect GroPIns formation, which occurs via PLB-mediated turnover of PI. Although an
increase in GroPIns formation is seen in the ira1 and ira2 mutants, an increase in PLB1 or PLB3
transcript only occurs in the double mutant (Figure 2-3 S). Thus, Ira1/2 regulation of the PLB
activity leading to GroPIns formation likely occurs at multiple levels. Potential post-transcriptional
mechanisms of regulation include localization or phosphorylation status. An alternate explanation
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is that yet another, uncharacterized, phospholipase exists for the formation of GroPIns in the
absence of Ira1/2. Importantly, the increased extracellular accumulation of GroPIns seen in the
absence of Ira1/2 cannot be explained by a decrease in its transport into the cell, as under the
growth conditions of the experiment (I+, high Pi), GIT1 is not expressed (102) (data not shown).
In total, this study indicates a role for IRA1/2 in the ability of cells to use GroPIns as a
phosphate source, in both GroPIns formation and transport, and in inositol biosynthesis. Future
studies could focus on determining the mechanisms for those disturbances, including whether they
involve the RAS/cAMP pathway or other, less defined, functions of Ira1/2. Further study of PLB
expression and activity in response to alterations in the Ras/cAMP pathway could help elucidate a
link between GroPIns metabolism and this pathway. However, the Ras/cAMP pathway was not
addressed further in this dissertation.
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Chapter 3 Examination of the roles and
regulation of the PLBs and Git1, including
examination of phenotypes associated with
altered dosage of these genes
Note: The work described in this Chapter was pursued as exploratory work to initially finish the
intended M.S. degree. In completing this probing work, and finding an interesting connection
between Ypk1 and Plb1, the project was extended into the basis for my Ph.D. dissertation work.
Therefore, many of the described experiments were not investigated in detail. None of the findings
in Chapter 3 are published and upon transition from the M.S. to Ph.D. requirements my project
was further defined. However, some of the cursory findings presented here helped lead us to the
Ypk1-Plb1 interaction thoroughly examined in Chapter 4 as the major project for my dissertation.
3.1 Introduction
The phospholipids of the plasma membrane are continually being synthesized and
degraded in response to environmental conditions. One aspect of this metabolism is carried out
through a recycling process consisting of i) deacylation of glycerophospholipids via the B-type
phospholipases (45,69,103), ii) the resultant production of intracellular and extracellular
glycerophosphodiesters (GPXs), iii) transport of the GPXs back into the cell via the transporter,
Git1 (64,93,102), and iv) the catabolism of and reutilization of the GPXs in cellular metabolism
(43,66). This recycling pathway will be referred to as the glycerophospholipid deacylation,
transport, and reutilization (GDTR) pathway. In this chapter, I report on preliminary studies on
the GDTR pathway that were initiated, but were not pursued to the level of publication. The topics
are as follows: i) morphological assessment of cells upon loss of Git1, loss of PLB1-3, and in cells
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utilizing of GroPIns as a sole phosphate source, ii) potential reacylation of GroPIns, and iii) genetic
interactions with the PLBs, one of which was pursued for completion of my Ph.D.
3.1.1 The Git1 glycerophosphodiester transporter
The Git1 permease of S. cerevisiae is a H+ symporter and a member of the major facilitator
superfamily (MFS) of proteins responsible for transporting GroPIns, and at a lower affinity
GroPCho, into the cell (104,105). Four homologues to S. cerevisiae GIT1 have been characterized
in the pathogenic yeast, C. albicans, named CaGIT1–4, each with varied affinity for particular
GPXs (104,106). In mammalian cells, Glut2 is the only GPX transporter characterized to date, but
others likely exist (67). GPX transporters are not essential proteins, but in phosphate limiting
conditions or in circumstances when GPXs are available, either in the growth medium or in the
human body, the ability to transport and utilize the GPXs can be advantageous, and even contribute
to virulence of an organism (106).
3.1.2 The S. cerevisiae B-type phospholipases
The three cell surface PLBs, Plb1, Plb2, and Plb3 deacylate the glycerophospholipids at
the plasma membrane to produce the GPXs that can then be transported into the cell by Git1
(45,61,69). The other PLB, Nte1, produces intracellular GroPCho at the ER membrane (103).
Published information about these enzymes in S. cerevisiae is reviewed in Chapter 1. Limited
studies have focused on characterizing the PLBs so there are many gaps in our knowledge of their
roles, specifically in how they affect cellular physiology. Moreover, the purpose of the production
and recycling of the glycerophosphodiesters is largely unknown.

36

PI

O
CO

O
CO

CH2
OH
CH
H2C

O

CH2

O
CO

CH

CH

OH

OH
O
O

P

OH

OH

O
OH

OH

O-

PLB
(lysophospholipase)

GPI AT or PLB ??

HO

O

LysoPI

HO

H2C

Fatty acid source

CH2

P
O-

PLB

PLB
(Transacylase)

HO

OH

O

OH

Fatty acid source

OH

OH

H2C

O
O

P

OH
O
OH

OH

GroPIns

+

Free Fatty Acids

OH

O-

Figure 3-1. Activities of the PLBs and hypothetical GroPIns acyltransferase activity.
PLB enzymes are known to hydrolyze PI to lysophosphatidylinositol (LysoPI), which can be hydrolyzed
again by the lysophospholipase activity of the PLB to produce GroPIns. PLBs are also able to add a fatty
acid to LysoPI in the presence of a fatty acid source, typically another phospholipid, via transacylase
activity. The existence of a PLB activity reacylating GroPIns has not been characterized. GPI AT, GroPIns
acyltransferase.

3.1.3 Potential ability of the PLBs to reacylate GPXs to produce lysoglycerophospholipids or
glycerophospholipids
The fate of the glycerophosphodiesters produced by PLB activity is only partially
understood. While Gde1 hydrolyzes GroPCho to produce glycerol-3-phosphate and choline (66),
no enzyme catalyzing the catabolism of GroPIns has been identified in yeast, although human
glycerophosphodiesterases have activity on GroPIns (51). One hypothesis is that the
glycerophosphodiesters, GroPCho and GroPIns, can be reacylated to produce LysoPC or LysoPI,
followed by additional acylation to produce the full lipids, PC and PI. This GroPCho
acyltransferase (GPC AT) activity has been observed in yeast and mammalian cells, but has
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remained controversial since enzymes catalyzing this activity remain elusive (107). Many putative
acyltransferase enzymes in yeast have been examined, but none were found to possess GPC AT
activity. The PLBs possess phospholipase, transacylase, and lysophospholipase activity, but
acyltransferase activity with a GPX as the substrate has not been attributed to the PLBs (Figure
3-1).
Importantly, PI is required for cell viability and is synthesized by the action of PI synthase,
encoded by PIS1 (Figure 1-3) (108). In the absence of Pis1, cells cannot make PI and will die.
However, if supplied with GroPIns and reacylation of GroPIns occurs, cells with non-functional
Pis1 hypothetically would survive. I explored this possibility in Section 3.3.7.
3.1.4 Morphology and cytoskeletal structure of S. cerevisiae cells
All cells must maintain an optimal architecture for survival. This includes a diverse range
of properties such as aggregation, gross morphology, and cytoskeleton structure. Yeast cells can
vary in shape and size depending on genetic background, but generally diploids are larger and
ellipsoidal, and haploids are smaller and more spherical (109). Screens of the yeast deletion set
have yielded morphological classifications of mutants into categories including WT, elongate,
round, football, clumpy, and other (110) and classified mutants as large (uge) or small (whi)
(111,112). These morphological classifications are based on cell size, shape, and aggregation
compared to WT cells. Cell size regulation through a balance of growth and proliferation is a
tightly controlled process in all eukaryotic cells.
Eukaryotic cells have the ability to aggregate together, resulting in formation of tissues and
organs in higher eukaryotes, or forming flocs, biofilms, and psuedohyphae in the single celled
yeast (113). These non-sexual aggregates in yeast can serve various purposes from protection of
the innermost cells, response to nutrient starvation, or a change in membrane properties causing
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sticking (114,115). This clumping, or flocculation, occurs due to interactions between the surface
glycoproteins encoded by the flocculation (FLO) genes, but recent data indicates involvement of
additional genes (113).
The yeast cytoskeleton, composed of actin filaments, microtubules, and septins, functions
in multiple processes in the cell including regulation of cell polarity, endocytosis, cell division,
maintenance of cell morphology, and intracellular vesicular transport (116,117). Contrary to
mammalian cells, yeast actin only forms three primary structures in the cell, actin patches, actin
cables, and the actinomyosin ring. Actin patches are dense networks of actin filaments localized
to the polarized growth zone and at sites of clathrin-mediated endocytosis, while actin cables are
bundles of actin filaments extending the long axis of the cell. The actinomyosin ring forms during
cytokinesis at the division site (reviewed in (116)).
Here, I will examine these structural properties – aggregation, morphology, and actin
cytoskeleton structure – upon disruption to the GDTR pathway.
3.1.5 Potential functional interactions between the PLB genes and other genes implicated in
the maintenance of cellular morphology
To better understand the roles of the PLBs in physiology, I proceeded to identify potential
functional interactions between the PLBs and other genes. The resources on the Saccharomyces
Genome Database, including the BioGRID interaction database, were used to narrow down a list
of interesting interactions from the total genetic and physical interactions identified for each of the
PLB genes (yeastgenome.org). Based on results that will be described in this chapter, interactions
that were potentially involved with cell morphology or actin cytoskeleton maintenance were of
primary interest, namely the genetic interactions between Ypk1 – Plb1 and Lge1 – Plb3. The
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interaction between Plb1 and Ypk1 proved to be the most interesting and was therefore pursued in
great detail in Chapter 4.
Because the glycerophospholipids are a significant structural component of the cell, I
hypothesized that alterations in various aspects of the GDTR pathway, might contribute to gross
morphological features of the cell. This hypothesis led me to ask, is gross morphology altered in
yeast cells upon loss of various genes in the GDTR pathway, specifically GIT1 and PLB1-3, and
furthermore, what particular cellular processes are impacted by PLB activity? Here, I investigated
several aspects of the GDTR pathway and how defects in the genes mediating this pathway can
affect cell physiology. This chapter will focus on four major areas: i) cellular morphology upon
loss of Git1 and upon utilization of GroPIns as a phosphate source in WT cells, ii) cellular
morphology and utilization of GroPIns upon loss of the PLBs and factors regulating the PLBs, iii)
ability of the cell to reacylate GroPIns to produce PI through activity of the PLBs, and iv)
functional interactions of the PLBs with other proteins affecting cell morphology and the actin
cytoskeleton.
3.2 Experimental Procedures
Strains and Media. The S. cerevisiae strains used in this study are shown in Table 3.1.
Strains were grown aerobically with shaking at 30ºC or 37ºC, as noted. Turbidity was monitored
by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo Spectronic
spectrophotometer. The cells were grown in various media as indicated. Yeast peptone dextrose
(YPD) was purchased from Fisher Scientific. Synthetic defined medium of yeast nitrogen base
(YNB) was made as described previously, but containing 2% glucose (93). YNB medium was
supplemented with either 200 µM KH2PO4 defined as low phosphate (LoPi) or 10 mM KH2PO4
defined as high phosphate (HiPi), or contained 6.8 mM phosphate if not specified. When indicated,
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YNB medium was supplemented with 75 µM inositol (I+) or did not contain inositol (I-). Plates
were prepared by adding 2% agar.
Yeast Transformation. Plasmid DNA and PCR products were transformed into yeast by
high efficiency lithium acetate chemical transformation procedure (118-120). Yeast cells were
grown to log phase, made competent with lithium acetate treatment, transformed with the desired
DNA, and transformants were selected on medium appropriate for the specific selectable markers.
When transforming cells with a drug resistance marker, as opposed to a nutritional marker, cells
were grown in non-selective rich medium for several hours prior to plating on selective medium.
PCR-mediated gene deletion. Gene deletions were performed by replacing all or part of the
targeted gene with a selectable marker (121). Primers were designed with approximately 60 base
pairs of homology to the target genomic sequence to be replaced and 20 base pairs homology to
the sequences of the selectable marker. The PCR products were purified, verified for correct size
by agarose gel electrophoresis, and extracted from the gel. The purified DNA fragments were
transformed into the desired yeast strains. Transformants were identified on selective medium.
Genomic DNA was isolated from potential deletion strains using a phenol-choloroform extraction,
and the gene deletion was verified by PCR. Verification of deletions was performed using two
primer sets, with both primers outside of the targeted deletion area, and the other set containing
one primer outside of the targeted deletion and one primer binding inside the inserted selectable
marker. Primers are listed in Table 3.2.
Calcofluor Staining. Cells were grown to an OD600 = 0.5. Calcofluor was added at a final
concentration of 0.2 mg/mL to an aliquot of culture. Suspension was mixed by vortex agitation
and incubated at room temperature for 5 minutes. Cells were pelleted and washed three times with
water. An aliquot of resuspended cells was examined by fluorescent microscopy.
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Table 3.1 S. cerevisiae strains used in this study (Chapter 3)
Strain

Genotype

Source

JPV 13

WT EG123; leu2-3, 112 ura3-52 trp1-1 his4 can1R

derived from EG123, D. Levin

JPV 140

leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆plb2∆

EG123, Susan Henry

JPV 201

BY4743 heterozygous diploid

JPV 203

a/alpha his3/his3 leu2/leu2 met15/MET15 LYS2/lys2
ura3/ura3 git1∆/GIT1
WT BY4741; his3∆1 leu2∆0 met15∆0 ura3∆0

JPV 212

his3 leu2 lys2 ura3 git1::KanMX

Research Genetics

JPV 381

a/alpha his3/his3 leu2/leu2 ura3/ura3 MET15/met15 LYS2/lys2

Research Genetics

JPV 399

WT BY4742; his3∆1 leu2∆0 lys2∆0 ura3∆0

Research Genetics

JPV 467

E1278b; ura3-52

Heitman lab at Duke University

JPV 469

E1278b; ura3-52 git1∆::KanMX

our lab, Claudia Almaguer

JPV 477

leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆

EG123, SH1082, Susan Henry

JPV 478

leu2-3, 112 ura3-52 trp1-1 his4 can1R, plb2∆

EG123, SH1083, Susan Henry

JPV 479

leu2-3, 112 ura3-52 trp1-1 his4 can1R plb3∆

EG123, SH1084, Susan Henry

JPV 480

leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆, plb2∆, plb3∆

EG123, SH1085, Susan Henry

JPV 569

WT ∑1278b; ura3-52

M. Cardenas

JPV 573

∑1278b; ura3-52 ira1::LoxP-nat

M. Cardenas

JPV 574

∑1278b; ura3-52 ira2::LoxP-nat

M. Cardenas

JPV 575

∑1278b; ura3-52 ira1::LoxP-nat ira2::LoxP-nat

M. Cardenas

JPV 617

BY4741; plb1::hph

our lab, Beth Surlow

JPV 618

BY4741; plb2::KanMX

our lab, Beth Surlow

JPV 619

BY4741; plb3::nat1

our lab, Beth Surlow

JPV 620

BY4741; plb1::hph, plb2::KanMX

our lab, Beth Surlow

JPV 621

BY4741; plb1::hph, plb3::nat1

our lab, Beth Surlow

JPV 622

BY4741; plb2::KanMX, plb3::nat1

our lab, Beth Surlow

JPV 623

BY4741; plb1::hph, plb2::KanMX, plb3::nat1

our lab, Beth Surlow

JPV 624

∑1278b; ura3-52, plb1::hph

our lab, Beth Surlow

JPV 625

∑1278b; ura3-52, plb2::KanMX

our lab, Beth Surlow

JPV 626

∑1278b; ura3-52, plb3::nat1

our lab, Beth Surlow

JPV 627

∑1278b; ura3-52, plb1::hph, plb2::KanMX

our lab, Beth Surlow

JPV 628

∑1278b; ura3-52, plb1::hph, plb3::nat

our lab, Beth Surlow

JPV 629

∑1278b; ura3-52, plb2::KanMX, plb3::nat

our lab, Beth Surlow

JPV 630

∑1278b; ura3-52, plb1::hph, plb2::KanMX, plb3::nat

our lab, Beth Surlow

JPV 636

BY4742; ypk1::KanMX

Research Genetics

JPV 645

BY4742; lge1::KanMX, plb3::nat

our lab, Beth Surlow

JPV 668

BY4742; plb1::hph

our lab, Beth Surlow

JPV 669

BY4742; ypk1::KanMX plb1::hph

our lab, Beth Surlow

JPV 679

BY4742; nte1::ble1

our lab, Beth Surlow

JPV 680

BY4742; plb1::hph, plb2::KanMX, plb3::nat, nte1::ble1

our lab, Beth Surlow

JPV 691

BY4742; ypk1::KanMX, nte1::ble1

our lab, Beth Surlow
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Table 3.2 Nucleotide sequences of primers used in this study (Chapter 3)
Name

Sequence

Notes

snr17 rev

5' CGG TTT CTC ACT CTG GGG TAC - 3'

RT-PCR primer for SNR17

snr17 for

5' TTG ACT CTT CAA AAG AGC CAC TGA - 3'

RT-PCR primer for SNR17

PLB1 For.

5' - GCA TAC ACC AAG GAG GCT TTG - 3'

RT-PCR primer for PLB1

PLB1 Rev.
PLB3 For.
PLB3 Rev.

5' - GAG TGG ATA GCA AGG AAG TGT CAC - 3'
5' - CCT GAC TTG GTC TTC CAT TAG GGA T - 3'
5' - GAT ACC TAC CGT CCG CAA - 3'

RT-PCR primer for PLB1
RT-PCR primer for PLB3
RT-PCR primer for PLB3

plb2 ForB

5' - ATC TCT GAG GCT ACT GAC GGT - 3'

RT-PCR primer for PLB2

plb2 RevB
Plb1/Hph F

5' - CGA AGA GTT TGA GTT AGA AGT GAC A - 3'
5’ CAA AAC CAT GAA GTT GCA GAG TTT GTT GGT
TTC TGC TGC AGT TTT GAC TTC TCT AAC CAG
CTG AAG CTT CGT ACG C ‘3
5’ AGA GCC TAA ATT AGA CCG AAG ACG GCA
CTA ATG ACA CTT AAG ACA CCA ATA AAA GGC
ATA GGC CAC TAG TGG ATC TG ‘3
5’ CTT ACG CAG ATG CAA TTA CGG AAC ATA TTA
CAG GCT AGC TCG CTA ATT TCT GGA CTT TCG
CTC ATT TAG CCC ATA CAT CC ‘3
5’ CAG AAG GGC TTC TAA ATT AGT CCA AAT AGT
CCA AAT AAT GCT GTT ATG GCA CCT AAC AAA
CTC ATT AGA GTG GGC AGA TGA TGT CGA GG‘3

RT-PCR primer for PLB2
Primer used for PLB1 deletion

5’ TAA GTA ATG ATA CGT CCA TTA TGT TCA AAA
ATT ATT ATC AGT TAC ATA TTC GCA ACA GCT
GAA GCT TCG TAC GC ‘3
5’ GCA AGA GAT ATT ATA CTG CTC CGG TAA ACA
TCA ATA AAG TAA GCA TAA TCA TAG CGC ATA
GGC CAC TAG TGG ATC TG ‘3
5’ GAA TAG AAA GGC TTG GCT CTA GTT TTT GCA
TGC GTT CAA TGA ATT GCA CTA CGA ACA ACG
ACA ACC CTT AAT ATA ACT TC ‘3

Primer used for PLB3 deletion

5’ CAA AAA ACG GTC ACC AAG GCG TTG GAA
GAT AGA AAT CTA TCA AAT ACT ATT TCT TCT
ATG ATC TGA TAT CAC CTA ATA AC ‘3
5’ CAT TAG CTC GAG GGT TTT GTT TTA TTT
TCT TTC CCG '3
5’ CAT TAG AGA TCT CTT CAG CCT ATT ATT
TAC GCA CCG '3
5’ CAT TAG CTC GAG CTG CGT AAG AAG TGT
TAC TTT AC '3
5’ CAT TAG AGA TCT CGG GCA ATG CTT TGG
TGA ATT ATT C '3
5’ CAT TAG CTC GAG TAC TTA TAT TAT TAT
GTG TGT AAT TTC C '3
5’ CAT TAG AGA TCT ACT ACC GCT TGT GCG
GAC CTG C '3
5’ CCC TAC TGC ATT AAT AAC AAT GAG TCC AGC
TTT TCT TGG GTC AGT TGA ATA TTT AAT GCA
GAA TCT TTT TAA GCA AGG AT 3’
5’ GTA TGA GCG GAT ACA CGG GAA ATA ATT
ATA GCA GAT ACT CAT CCA CTC CTC CGA GAC
AAA CAC ATA CCT AAT ATT ATT GC 3’

Primer used for NTE1 deletion

Plb1/Hph R
Plb2/KanMX
F
Plb2/KanMX
R
Plb3/Nat F
Plb3/Nat R
Nte1/ble F

Nte1/ble R
PLB1 XhoI
Reverse
PLB1 BglII
Forward
PLB2 XhoI
Reverse
PLB2 BglII
Forward
PLB3 XhoI
Reverse
PLB3 BglII
Forward
LGE1/Leu2
reverse
Lge1/Leu2
forward
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Primer used for PLB1 deletion
Primer used for PLB2 deletion
Primer used for PLB2 deletion

Primer used for PLB3 deletion
Primer used for NTE1 deletion

Primer used for PLB promoter
insertion into pBH315
Primer used for PLB promoter
insertion into pBH315
Primer used for PLB promoter
insertion into pBH315
Primer used for PLB promoter
insertion into pBH315
Primer used for PLB promoter
insertion into pBH315
Primer used for PLB promoter
insertion into pBH315
Primer used for LGE1 deletion
Primer used for LGE1 deletion

Actin Staining with Phalloidin-FITC. The protocol for actin staining was adapted from
Reizman et al., Pringle et al., and the current protocols in molecular biology (122,123). Cells were
grown in YPD media to log phase at an OD600 ~ 0.8. To 1 mL of culture 100 µL of 37%
formaldehyde was added to fix the cells. The suspension was incubated at room temperature for 1
hour followed by centrifugation at 8,000 rpm for ~5 mins to collect the pellet. Cells were washed
three times with 1mL aliquots of phosphate buffered saline (PBS). The pellet was resuspended in
1 mL of 0.2% Triton-X100/PBS solution and incubated at RT (25C) for 10 minutes. The cells
were pelleted and washed three times with 1 mL aliquots of PBS followed by resuspension in 100
µL of PBS. To 50 µL of the suspension, 8 µM FITC-phalloidin methanol stock solution was added
followed by incubation on ice in the dark for 90 minutes. Cells were washed five times with 1 mL
aliquots of PBS. Final pellet was resuspended in PBS. An aliquot was placed onto a microscope
slide and allowed to air dry in the dark. 10 µL of ProLong Gold was placed over the sample for
preservation and for adherence of the cover glass (#1.5 thickness). The slides were stored
overnight in the dark to allow the Prolong gold to solidify. All slides were stored at -20C until
viewing by confocal microscopy.
Microscopy. Brightfield and fluorescent microscopy were performed on a Nikon
Microphot-SA microscope with attached camera. Confocal microscopy was performed on the
Zeiss Axio Observer Z1 confocal microscope, and images were obtained with HCImage software
(Zeiss). Scanning Electron Microscopy (SEM) was performed by Dr. Donna Stolz at the University
of Pittsburgh.
Construction of the PLB-lacZ containing plasmids. Plasmids containing each of the PLB
promoters were constructed previously in the lab (JPV 226, 228, and 230) but were non-functional
so new constructs were made. The PLB promoters were amplified by PCR from the respective
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plasmids using hybrid primers. The primers were engineered to contain BglII and XhoI restriction
sites (Table 3.2). PCR products were purified from agarose gels using a gel extraction kit according
to the manufacturer instructions (Qiagen). The PLB promoter products were cloned into the
intermediate TOPO pCR2.1 vector using the TOPO TA Cloning Kit with One Shot TOP10
electrocompetent cells (Invitrogen). The potential pCR2.1-PLB promoter plasmids were isolated
from transformants and checked for the correct insertions by restriction digest with EcoRI. The
constructed intermediate pCR2.1-PLB promoter vectors (JPV 325, 327, and 328) and the pBH315
(JPV 161) were restriction digested with BglII and XhoI. The digested DNA was gel purified and
extracted. The pBH315 backbone was treated with CIP followed by gel purification and extraction.
Ligation of the pBH315 backbone with the PLB-promoter DNA was carried out with T4 Ligase at
16ºC for 16 hours. Ligation products were transformed into E. coli competent cells. Plasmids
isolated from transformants were checked for the correct PLB promoter insertion by restriction
digest with BglII and XhoI as well as by BglII and SphI digestion.
RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in
YNB medium under the conditions specified in the text. RNA extraction and qRT-PCR was
performed as described in Section 2.3.1.
β-galactosidase assays. Using cells grown in liquid media β-gal assays were performed as
described in Chapter 2.3.1. β-gal activity assays from cells grown on plates were performed by
plating the strains transformed with lacZ expression plasmids onto YNB – URA I+ plates
containing X-GAL and incubated at desired temperature. Formation of a blue color in the cell
patch indicated β-gal activity.
PIS1 promoter replacement with the GAL1 promoter. The PIS1 promoter was replaced
with the GAL promoter in the genome by amplifying DNA for insertion by PCR from the plasmid
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pFA6a-KanMX6-PGAL1-3HA with hybrid primers named pFA6a-KanMX6-PGAL1-3HA F1
(5'GTACCGATGAGATGAGATGAG…3')

and

pFA6a-KanMX6-PGAL1-3HA

R1

(5'ATTGGGAATATA….3'), each containing homology to the GAL promoter and region
surrounding the PIS1 promoter. The PCR product was gel purified and transformed into JPV 13
and JPV 203 and plated onto YT+Galactose+G418 plates.
Sporulation and tetrad dissection. Sporulation media used included, KAc (0.05% glucose,
1% potassium acetate, 0.1% yeast extract in DI water), and minimal media (10% potassium acetate
and 0.05% zinc acetate). Sporulation media supplemented with amino acids and bases
complementary to the strain auxotrophies were also used. Sporulation and tetrad dissection was
carried out as published in Ausubel et. al. (99). Diploids to be sporulated were grown to an OD600
= 3 in 5 mL of YPD medium, cells were harvested for 5 minutes at 1200 x g, washed once in water
and resuspended in 1 mL of sporulation medium. Cells were sporulated at 30ºC for up to two
weeks or until spores were microscopically visible. Cells were washed three times in sterile water
and resuspended in 5 mL of sterile water. 30 µL of the cell suspension was diluted with 270 µL of
sterile water and 3 µL of diluted glusulase was added to disrupt asci by vortex agitation.
Suspension was incubated at room temperature until half of all tetrads had a disrupted ascus wall
(2 - 6 minutes). Tetrad dissection was performed by placing treated spores in two parallel lines
across the surface of the spore dissection plate (medium specified in text). Using the dissection
needle, groups of four spores were separated into a line adjacent to the original position of the
tetrad. After dissection, plates were incubated at 30ºC.
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3.3 Results
3.3.1 Cell morphology is altered upon loss of the Git1 transporter and in WT cells utilizing
GroPIns as a sole phosphate source
To begin understanding the role of Git1 in cellular morphology, in conjunction with its
substrate, GroPIns, several phenotypic analyses were performed. Previous large scale
morphological screens of the yeast deletion set classified the heterozygous git1∆/GIT1 diploid
strain as football shaped (110). Here, microscopic examination of WT and the heterozygous
git1/GIT1 diploid strains revealed minor differences in cell shape between the two strains grown
in YPD, YNB I+ HiPi, and YNB I+ LoPi media (Figure 3-2). Each cell was classified as “football”
shaped, defined as being pointed on both ends, or as “other”, based upon subjective visual
examination and tallying. The percentage of football shaped cells in the git1∆/GIT1 strain was
roughly the same in each of the media examined, suggesting phosphate concentration does not
significantly affect cell shape.
Transported into the cell by Git1, GroPCho or GroPIns can be supplied as the sole
phosphate source for yeast cells (61). These metabolites are also found at physiologically relevant
concentrations throughout different regions of the human body (51,124). We sought to determine
if the presence of GroPIns in the medium facilitated any changes in the morphology of WT cells.
Microscopic observations of WT cells grown in YNB and YPD medium, containing GroPIns in
addition to KH2PO4 as an endogenous phosphate source, resulted in increased cellular aggregation
(Figure 3-3).
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Figure 3-2. WT and git1∆/GIT1 diploid strains display minor differences in cell shape.
WT (JPV 381) and git1∆/GIT1 (JPV 201) were grown to log phase in YPD, YNB I+ HiPi, and YNB I+
LoPi media. A, An aliquot of each culture was examined under the light microscope. Strains were grown
in duplicate and pictures of at least 5 frames per culture were obtained. Cells grown in YPD at 400X
magnification are shown as a representative example. B, Images were examined and the percentages
of football shaped cells was determined for each strain and condition. Cells in the budding stage were
only considered when they were over half the size of the parent cell. All classifications were subjective
based on my discretion.
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Figure 3-3. WT cells display increased aggregation in the presence of GroPIns.
WT cells (JPV 13) were grown to single colonies on YPD and I+ plates at 30ºC. A portion of an
individual colony was resuspended in 15 µL of water, agitated by vortex mixing for 30 seconds, and
sonication for 30 seconds. An aliquot of the suspension was viewed under the light microscope at 200X
magnification. At least 3 colonies under each condition were observed. Pictures are representative of the
entire data set.

Over the course of my experiments, I observed that WT yeast cannot grow with GroPIns
as the phosphate source when grown at an elevated temperature of 37ºC, prompting me to examine
this phenomenon in more detail. WT strains in several genetic backgrounds (EG128, JPV 13;
BY4741, JPV 203; ∑1278b, JPV 569) can grow on plates with GroPIns as a phosphate source at
37ºC (Figure 3-4A), but were defective in growth in liquid media with GroPIns as the phosphate
source (Figure 3-4 B and C). When WT cultures are started at an OD600 ≤ 0.02, after 60 hours of
growth at 37ºC the culture in YNB I+ NoPi + 200 µM GroPIns media does not reach an OD600 >
0.08, but in YNB I+ LoPi media the OD600 > 1.5 (data not shown). When WT cells were grown in
YNB I+ NoPi + 200 µM GroPIns liquid media initially at 30ºC, and then shifted to 37ºC, growth
did not stop, but the cultures reached stationary phase at a lower density (Figure 3-4B).
Furthermore, the lower the cell density at the time of temperature shift, the greater the amount of
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reduction in final density (data not shown). Preliminary studies to determine if a potential 96-well
plate screen could be performed revealed WT could grow in YNB I+ NoPi + 200 µM GroPIns
media at 37ºC in a 96-well plate without shaking, albeit minimally compared to 30ºC (Figure
3-4C). To use as a screen in the future, tests would need to be completed in 96-well plates with
shaking at 30ºC and 37ºC, to mimic traditional liquid growth in 5 mL cultures grown in a rotating
wheel.

Figure 3-4. WT cells have slowed growth when grown in media requiring utilization of
GroPIns as a phosphate source at 37ºC.
A, WT (JPV 203 and JPV 569) were grown in YNB I+ LoPi media at 30ºC and diluted to equal densities
for plating to single colonies. Aliquots were spread onto YNB I+ LoPi and YNB I+ NoPi + GroPIns plates
and incubated at 30ºC and 37ºC for 2 days. B, WT (JPV 203) cultures were started at OD600 = 0.005 in 5mL
cultures in listed media and grown at 30ºC in rotator wheel, and subsequently split after 12 hours (red line),
for growth at 30ºC and 37ºC. C, WT (JPV 203) cultures were started at OD600 = 0.002 in 200 µL of media
in a 96-well plate in the listed media and grown at 30ºC and 37ºC. Data are means ± S.E. of at least triplicate
cultures.
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3.3.2 Growth of the PLB mutants utilizing GroPIns as a phosphate source.
The preliminary data suggesting WT cells display altered growth and aggregation in the
presence of GroPIns prompted me to examine potential physiological or morphological alterations
in cells lacking the B-type phospholipases, which produce GroPIns, when grown in the presence
or absence of GroPIns in the medium. The plb123∆ (JPV 630) strain can grow with GroPIns as
the sole phosphate source at 30⁰C, although slower than WT (Figure 3-5A). Microscopic exam of
the cultures revealed the plb123∆ strain displays larger average cell size compared to WT (Figure
3-5 B and C). Furthermore, abnormally large (XL) cells, with large vacuoles, were observed in
plb123∆ cells when grown with 200 µM GroPIns as the phosphate source, and no XL cells were
observed under the same condition in WT or in corresponding cultures containing 200 µM KH2PO4
(LoPi) as the phosphate source. Cells were also examined in YNB I+ LoPi medium containing
additional 200 µM GroPIns, but a notable increase in XL cells was not observed in this medium
for WT or plb123∆ (data not shown). This suggests that the forced utilization of GroPIns as a
phosphate source in the absence of the PLBs results in the most extreme phenotype. Suspension
of cells grown in corresponding media, but on agar plates, produced trends similar to those
observed in the liquid media (data not shown). In media requiring utilization of 200 µM GroPIns
as the phosphate source, XL cells were observed occasionally in the single and double PLB
mutants examined, and subjectively appeared to be most prevalent in the plb2∆, plb12∆, and
plb123∆ strains (Figure 3-6). However, since there was not an obvious change in morphology
compared to WT a more complete quantitative analysis was not performed in the single or double
PLB deletion strains.
Preliminary scanning electron microscopy (SEM) images of WT and plb123∆ cells
(Courtesy of Dr. Donna Stolz at the University of Pittsburgh) revealed large invaginations in the
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surfaces of these XL cells (Appendix A 2). The cause of this observation is unknown, but suggests
major cellular alterations when PI deacylation is disrupted, and GroPIns is used as a phosphate
source. This result may indicate PLB mediated turnover is required for normal physiology when
GroPIns is incorporated into cellular metabolism.

Figure 3-5. GroPIns can be used as a phosphate source upon loss of the cell surface
associated PLBs, but results in aberrant morphology.
A, WT (JPV 13) and plb123∆ (JPV 480) were grown in YNB I+ LoPi media and inoculated into listed test
media at starting OD600=0.005. B, Aliquots of culture were removed and examined microscopically.
Quantitation of cell area from log phase cells growing in equivalent concentrations of KH2PO4 or GroPIns
was performed using ImageJ software. Several fields from at least 3 separate cultures were analyzed. C,
Phase contrast microscopy of representative fields at 400X magnification after 48 hours of growth.
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Figure 3-6. Cells lacking single deletions of
the PLB genes display some instances of
morphological abnormalities.

examined by

WT (JPV 13), plb1∆ (JPV 477), plb2∆ (JPV 478),
plb3∆ (JPV 479), plb12∆ (JPV 140) and plb123∆ (JPV
480) were grown in in I+ LoPi media and inoculated
into test media at OD600=0.005. Cultures were
phase contrast microscopy at 400X magnification
after 38 hours of growth. Frames are representative of
each condition.
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Together the morphological abnormalities identified in the plb123∆ strain and in cells
grown on GroPIns as a phosphate source could indicate potential alterations in the cytoskeleton
cell wall, plasma membrane, and/or vacuolar morphology. Before pursuing other tests, including
growth and drug susceptibility assay, another set of PLB mutants was constructed in two different
strain backgrounds detailed in the next sections.
3.3.3 Deletion of one or more PLB genes does not alter growth rate
Preliminary experiments with PLB mutants in the EG123 background produced
inconsistent results, prompting me to make all of the deletion strains in our standard laboratory
strains. Deletion of each of the PLBs, PLB1, PLB2, and PLB3 were made singly and in
combination in the BY4741 and ∑1278b backgrounds. Additionally, NTE1 was deleted singly and
in the plb123∆ strain in BY4741. Growth of all the newly constructed PLB deletion strains (JPV
617 – 630, Table 3.1) was monitored in several types of media including: YNB LoPi, YNB HiPi,
and YNB NoPi + GroPIns, all with and without inositol. No major differences in growth between
WT and plb123∆ in respective media were observed (Figure 3-7). As demonstrated in previous
publications, and shown in Figure 3-7, growth on GroPIns results in a long lag phase. Microscopic
examination of the plb123∆ strain when grown on GroPIns as the phosphate source revealed the
presence of XL cells consistent with the observations in the EG128 background. Interestingly, WT
cells in both the BY4742 and in the ∑1278b backgrounds also appeared to have more XL cells
when grown on a medium requiring GroPIns utilization compared to low or high phosphate media,
although this was a visual observation and not quantified.
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Figure 3-7. Loss of PLB 1, 2, and 3 does not alter growth compared to WT.
Indicated strains were pre-grown in YNB I- LoPi medium and inoculated at a low starting density into the
desired medium. Optical density (A600) of the cultures was monitored over time.

3.3.4 The plb123∆ strain has increased sensitivity to the actin destabilizer, Latrunculin A
Actin cytoskeleton disruption can cause abnormalities in cell morphology. Furthermore,
the yeast fitness database identified plb3∆ as having increased sensitivity to Latrunculin A (LatA),
an actin destabilizing drug that inhibits actin polymerization. LatA inhibited growth of various
combinations of the double PLB mutants, and most severely inhibited growth of the triple plb123∆
mutant, whereas Lat A did not affect growth of the single PLB deletion mutants (Figure 3-8). Cell
viability of WT and plb123∆ strains after growth in the presence of LatA was similar based upon
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plating equal amounts of cells and counting individual colonies (data not shown). Observation of
growth sensitivity to LatA prompted us to microscopically examine the actin cytoskeleton.
Preliminary observations revealed that in fixed cells stained with TRITC-phalloidin in the absence
of LatA, the actin cytoskeleton of the plb123∆ cells appeared to be similarly organized to the WT
cells, both strains exhibiting actin patches and cables, typical of yeast cells (Appendix A 3). In the
presence of LatA, actin patches are visible in the WT, but interestingly, no defined organized actin
structures are visible in plb123∆ (Appendix A 3). This microscopic observation was not pursued
quantitatively and would require more replicate measures.

Figure 3-8. Loss of multiple cell surface PLBs in the BY4741 background increases
sensitivity to the actin destabilizer, Latrunculin A.
The cells were grown from equal starting densities at 37C in YPD media with 1µM LatA (in DMSO) or
with solvent. Inhibition by LatA for each strain was determined by calculating the percentage of growth in
LatA containing media compared to growth in the control for the single (A), double (B), and triple (B)
mutants after 25 hours of growth. Growth curves of WT and plb123∆ with and without presence of LatA
(C). Chemical structure of Latrunculin A (D).

56

3.3.5 Phenotypic analysis of WT and strains bearing deletion of the PLB genes upon exposure
to stressors targeting the plasma membrane and the cytoskeleton
To continue our analysis of PLB function, growth was examined in the presence of several
stressors shown in Table 3.3. In summary, no differences in visible growth sensitivity to the
mentioned stressing agents were noted between WT and plb123∆ strains under the conditions
examined (liquid and/or plate growth assays in BY4741 and ∑1278b backgrounds, data not
shown). The strain bearing deletion of all four S. cerevisiae PLBs (plb123∆ nte1∆) was constructed
in the BY4741 background and growth studies showed no alteration in sensitivity to calcofluor,
NaCl, or SDS compared to WT (data not shown).
Table 3.3 Chemical cell stressors evaluated and their targets
Drug/Compound
Targeted process/Molecular target
Name
SDS, NaCl,
Plasma membrane disturbing agents
CdCl2, CuSO4
Calcofluor
Cell wall destabilizer
Benomyl
Microtubule depolymerizing drug
Nocodazole
Interferes with microtubule polymerization
Amphotericin B Ergosterol metabolism; Associates with ergosterol causing ion leakage
through the membrane
Terbinefine HCl Ergosterol metabolism; Inhibits the enzyme squalene monoxygenase
preventing the conversion of squalene to lanosterol in the ergosterol
biosynthetic pathway
Ketoconazole
Ergosterol metabolism; Inhibits enzyme that converts lanosterol to
ergosterol
Nystatin
Ergosterol metabolism; Binds to ergostrol causing K+ ion leakage through
the membrane

3.3.6 Role of phosphate and growth phase in PLB expression
In addition to identifying physiological processes associated with PLB activity, I wanted
to examine how the PLB genes are regulated at the transcriptional level, and how that regulation
impacts the broader GDTR pathway. I hypothesized that the PLB genes may be regulated by
phosphate, as is the GroPIns transporter GIT1. Additionally, PLB transcript levels were compared
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in log versus stationary phase cells, at 30ºC versus 37ºC, and in cells exposed to various stressors
(SDS, NaCl, calcofluor, amphotericin B, LatA, choline, terbinefine, and nystatin).
Plasmids containing each of the PLB promoters controlling the lacZ gene were constructed
as described in Experimental Procedures (Chapter 3.2). The lacZ vectors and β-gal assays were
used to obtain preliminary data for PLB expression (data not shown), however, real time qRTPCR was used as a more sensitive method to examine message levels under conditions of interest.
Additionally, using the Yeast Tract database (yeastract.com), I identified potential transcription
factors with binding sites in the promoters of the PLB genes that were likely involved in altered
morphology and/or disrupted actin cytoskeleton. Strains bearing deletion of the genes encoding
the transcription factors Msn2, Msn4, Crz1, Sfl1, Xbp1, Hac1, Sko1, and Yap1 were screened for
changes in PLB gene expression. Noticeable differences in PLB promoter driven β–gal activity
were observed in the msn2∆, msn4∆, and crz1∆ strains, but these were preliminary and not
followed up at this stage. However, β–gal assays in WT strains transformed with the PLB-lacZ
vectors suggested all three genes encoding the cell surface PLBs (PLB1-3), have greater expression
at 37ºC compared to 30ºC.
Since the Git1 transport activity is regulated by phosphate levels (102), I examined PLB
gene regulation by phosphate levels. In agreement with the transport data, GIT1 transcript levels
measured by qRT-PCR were found to be depressed in YNB HiPi medium compared to YNB LoPi
medium (Figure 3-9B). Unlike GIT1, the PLB1-3 genes are not highly regulated by phosphate
availability (Figure 3-9C). No difference in message abundance was noted in PLB1 or PLB2 in
WT grown in HiPi versus LoPi medium, while PLB3 message was approximately twice as
abundant in cells grown in HiPi compared to LoPi. Message abundance of PLB1-3 in WT cells
gown in YNB + GroPIns media compared to YNB LoPi media was not significantly different
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(Figure 3-9D). I also report that in WT cells PLB2 and PLB3 message levels decrease in stationary
phase, while the PLB1 message increases in stationary phase compared to levels in log phase cells
(Appendix A 4).
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Figure 3-9. Glycerophosphodiester transport via Git1, not production via Plb1-3 is
regulated by phosphate availability.
A – C, Relative message abundance of GIT1, PLB1, PLB2, and PLB3 in a WT strain grown in low Pi
compared to high Pi containing medium (A and B) or low Pi compared to GroPIns containing medium (C).
Total RNA was extracted and transcript levels were analyzed by real-time RT-PCR using the comparative
∆∆CT method. Data were normalized to the amount of the endogenous control mRNA, SNR17, and
expressed relative to the value in WT cells grown in high Pi medium. Values represent the means ± S.E. of
at least 3 individual cultures each assayed in triplicate. Student’s t-test was performed to compare
expression of each gene in media compared to YNB LoPi (A, p = 0.015; B, p = 0.028).
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3.3.7 Lethality in the absence of PI synthase cannot be rescued by the presence of GroPIns
in the medium
A series of experiments were performed in an attempt to determine if a
glycerophosphodiester (GPX) reacylation pathway exists in S. cerevisiae, and if so, does it require
the PLBs. GroPIns was chosen as the GPX substrate since GroPIns was shown to be the most
abundant glycerophosphodiester accumulating in the media of S. cerevisiae, with GroPCho and
glycerophosphoethanolamine present at much lower levels (125). We hypothesized that GroPIns
enters cellular metabolism through reacylation to LysoPI and/or PI. Several approaches to
determine if a reacylation synthesis pathway for PI exists in the cell will be briefly summarized
here, however no evidence for reacylation of GroPIns to PI was obtained. The experimental goal
in each of these approaches was to show that when the essential gene PIS1 is deleted or made
nonfunctional, the cells can retain viability if the medium is supplemented with GroPIns,
suggesting that GroPIns is reacylated to produce the essential PI (Figure 3-1 and Figure 3-10).

Figure 3-10. Known PI synthesis through Pis1 activity and hypothetical PI synthesis by
GroPIns acyltransferase activity.
PI is synthesized from CDP-DAG and inositol through a condensation reaction catalyzed by PI Synthase
(Pis1) and can be catabolized through the action of Plb3 to produce GroPIns. A PI synthesis pathway by
GroPIns reacylation through GroPIns acyltransferase (GPI AT) activity is currently uncharacterized.
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Using published methods described for chromosomal promoter replacement and PCR
based gene deletion, the endogenous PIS1 promoter was replaced with the GAL1-inducible
promoter (121,126). Transformants containing the GAL1 promoter were obtained, but while the
transformants grew better on medium with galactose, cells continued to grow on glucose medium.
In conclusion, the GAL1 promoter was too leaky to perform the depletion experiment. A few years
later, the Lopes lab published work on a pis1∆ haploid strain containing a GAL-PIS1 plasmid
(127). They kindly sent us this strain, but preliminary tests revealed that it still grows fairly well
on medium containing glucose, as well as on galactose medium, corroborating my attempt.
A diploid pis1∆/PIS1 (JPV 605) strain was transformed with the pYES2CT-HA-PIS1
plasmid and transformants were sporulated in several types of sporulation media. Tetrads were
dissected to isolate individual spores and the resulting individual colonies were tested to determine
which were haploid by a mating assay, tested for PIS1 deletion by G418 resistance, and checked
for presence of the PIS1 containing plasmid by growth on –URA plates. Only two of the spores
screened met all of the requirements. These strains was propagated on galactose containing plates.
Equal starting amounts of cells were grown in liquid and on plates in the following media: YNB
I- LoPi, YNB I- LoPi + GroPIns + 5-FOA, and YNB I- LoPi + 5-FOA (some containing 5-FOA to
induce loss of the plasmid and hence produce a pis1∆ strain). Growth occurred on all of these
media indicating that even though the strain was confirmed to have PIS1 deleted and contains the
PIS1 plasmid, something else was compensating for the deletion, or the cell had another copy of
PIS1. Checking for PIS1 deletion by PCR revealed bands consistent with the presence of both a
WT copy of PIS1 and a copy in which URA3 was inserted, suggesting that they are not truly
haploid, that a recombination event occurred with PIS1 on the plasmid, or that mixed colonies
were obtained. This question was not pursued further.
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Direct deletion of PIS1 in a haploid strain in the presence of GroPIns was attempted. Since
PIS1 is an essential gene this attempt would only be successful if GroPIns can be reacylated to
rescue the PIS1 deletion. Homologous recombination by insertion of KanMX and transformation
onto plates containing GroPIns resulted in transformants, but the insert was never in the correct
location. As a control, PIS1 was successfully deleted in a diploid strain using the same methods
used for the haploid. Because selection for KanMX resulted in significant background growth,
PIS1 was also directly deleted by homologous recombination by insertion of URA3. Many
successful transformants appeared in the control diploid strains, and a few transformants appeared
in the haploid strain. Despite these strains being verified to be haploids through a mating assay,
and PCR checking revealed several transformants contained the URA3 insert in the correct
location, interestingly a band indicating the presence of a WT copy of PIS1 also appeared. The
results suggest there was an extra copy of the chromosome, or this region was under pressure to
duplicate.
A pis1/PIS1 diploid was constructed in a diploid strain known to have a high sporulation
efficiency (JPV 381). The deletion was made by insertion of URA3 and verified by PCR. The
newly constructed diploid pis1∆/PIS1 (JPV 616) was efficiently sporulated in sporulation media
(1% potassium acetate, 0.1% Bacto Yeast Extract, 0.05% dextrose). Tetrad analysis by pulling
spores directly onto plates containing GroPIns produced maximum of two developing colonies per
tetrad indicating that the pis1∆ haploid strain is unable to be rescued by the presence of GroPIns
in the medium. Therefore, it is unlikely that GroPIns is able to be reacylated in order to rescue a
pis1∆ mutant.
In summary, I was unable to rescue a pis1∆ mutant through GroPIns supplementation. This
could mean either that GroPIns cannot be reacylated, cannot be reacylated efficiently enough to
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rescue the lethality, that genes responsible were not expressed under the conditions used here, or
that Pis1 has another essential function besides synthesis of PI. To date, no enzyme has been
characterized with acyltransferase activity to reacylate GroPIns, but recent work in the Patton Vogt
lab in collaboration with the Stymne lab indicates GroPCho can be reacylated by a novel gene
product in both yeast and plants.
3.3.8 The functional Interaction between the PLBs and other genes, specifically Ypk1 and
Lge1
The described results concerning morphological and actin cytoskeletal abnormalities
prompted me to examine the genetic interactions between Ypk1 – Plb1 and Lge1 – Plb3 because
of their known involvement in actin dynamics and cell morphology, respectively. The Ypk1 – Plb1
interaction became the primary focus for this dissertation and is discussed in Chapter 4. A genomescale interaction study identified a negative genetic interaction between LGE1 and PLB3, in which
the lge1∆ plb3∆ double mutant exhibited slower growth than either single mutant alone (128).
Notably, the LGE1 mutant exhibits a large cell phenotype under optimal growth conditions (129).
LGE1 is a verified ORF, predicted to be localized to the nucleus, but the function of the protein is
currently unknown. Together with my data concerning the PLBs, I hypothesized this interaction
impacted processes involved with maintaining proper cell morphology. Only preliminary data was
collected examining the Plb3-Lge1 interaction. The lge1∆ plb3∆ strain was constructed to begin
assessing the interaction between the two genes. Consistent with the published large scale genetic
screen, the lge1∆ plb3∆ strain displayed slowed growth compared to the single deletion strains
(Appendix A 5). No further studies were performed with the lge1∆ plb3∆ strain in this dissertation,
but a follow-up of this interaction may elucidate a novel role for the PLBs, specifically Plb3, in
maintaining optimal morphology.
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3.4 Discussion
Perturbation to the GDTR pathway by deletion of GIT1 or the PLB genes, or by forcing
utilization of GroPIns as a sole phosphate source results in a variety of morphological changes in
the cell. These morphological changes are known to be regulated by and/or affect a diverse range
of processes. Since all of the players in the pathway have functional homologs in higher eukaryotes
and because GroPIns is present in the human body, this has relevance for higher eukaryotes.
Preliminary microscopic studies indicate the presence of GroPIns in the medium causes
increased clumping in WT cells (Figure 3-3). Genetically, aggregation of cells generally occurs
upon induction of the FLO genes, which are in part regulated by various environmental conditions
including cations, pH, temperature, sugars, and ethanol (115). In some fungi aggregation can lead
to formation of hyphae and biofilm structures, which contribute to pathogenesis. Possibly, GroPIns
could be a signal promoting aggregation. Future studies may examine the expression of the FLO
genes, or other genes implicated in flocculation. A sedimentation test would provide a quantitative
assessment of differences in aggregation (113).
Morphological changes in the cell can provide clues for elucidating the function of
particular proteins. The football shaped cells observed upon loss of GIT1 are consistent with a
published screen classifying the git1∆ mutant as football shaped (110). Altered cell shape can be
due to a variety of factors involving the cell wall, plasma membrane, and cytoskeleton. Most
interestingly, loss of the three cell surface PLBs resulted in XL cells, membrane invaginations, and
actin cytoskeletal defects when forced to utilize GroPIns. My results suggest that the presence of
GroPIns exacerbates disruptions to cell morphology in strains or conditions where morphology is
already compromised, such as upon loss of the PLBs or upon heat stress (Figure 3-4 and Figure
3-4).
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To elucidate the underlying mechanism for the observed changes in cell size and
morphology upon loss of the PLBs, I examined the effect of stressor known to perturb the cell
wall, plasma membrane, and cytoskeleton. Increased sensitivity to LatA in plb123∆ yeast (Figure
3-8) and actin staining (Appendix A 3) indicate loss of the PLBs results in a compromised actin
cytoskeleton, providing a possible explanation for some of the observed morphological alterations.
However, growth alone is not a complete measure of defects in plasma membrane and cell wall
stability so these preliminary studies do not entirely rule out plasma membrane or cell wall defects
in plb123∆ yeast cells.
Membrane expansion and failure to divide can result in XL cells to develop (111). An
experiment involving synchronization of cells and subsequent monitoring of division could also
be employed. Since cultures did not produce uniformly XL cells, a series of measurements from
mother and daughter cells would be useful to determine if there is a significant alteration in cell
size in plb123∆ yeast.
There are a few descriptions in the literature describing cellular circumstances that produce
large invaginations of the yeast cell membrane, however the cause of the large invaginations
observed in plb123∆ cells is unknown. Published observations have demonstrated the presence of
invaginations in cells including furrow like invaginations at the membrane compartment
containing Can1 (MCC) domain and the sub-adjacent eisosomes (130-133), invaginations in
regions termed PtdIns[4,5]P2 enriched structures (PES) (132), and invaginations in cells that are
lacking two of the three genes encoding Sac1-containing phosphatases, INP51, INP52 and INP53
(133,134). A recurring theme relating to cellular invaginations are the importance of
phospholipids, particularly the phosphorylated phosphatidylinositols (PIPs), also essential
regulators of the actin cytoskeleton (135,136). Interestingly, addition of glucose or ergosterol will
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induce major changes in the PIPs (137,138). For example, addition of glucose causes rapid
hydrolysis of the PIPs to produce the GroPIPs (59), an activity that has been suggested to be
mediated by the PLBs. Therefore, it is tempting to speculate that these structures could be related
to PtdIns[4,5]P2 levels and Sac1 function. Evaluation of these possibilities requires further
experimentation.
Here, I show that the PLBs are transcriptionally regulated by temperature. Although
preliminary experiments by β-gal accumulation assays did not indicate changes in transcription
upon LatA treatment, it would be interesting to examine PLB message by the more sensitive qRTPCR method. Furthermore, using the β-gal assays I was unable to conclusively identify
transcription factors strictly regulating the PLB genes, however further examination of the TFs of
interest, Msn2/4 and Crz1, under various stress conditions will shed light on PLB gene regulation
(Chapter 4.3.6). Regulation data compiled on SGD suggests several other transcription factors of
interest that are shown to regulate PLB message levels under elevated temperature, various media,
exposure to drug perturbations, or in different growth phases, indicating the combinatorial control
regulating the PLB genes.
The PLBs have phospholipase, transacylase, and lysophospholipase activities (45,69). The
ability of the PLBs to acylate GroPIns to PI has not been shown, and the studies described in this
chapter suggest the cell does not have the capability to re-acylate GroPIns, or not sufficiently
enough, to rescue growth in the absence of PI synthase under the conditions tested here. However,
the ability of yeast and plants cells to reacylate GroPCho has been shown in vitro (107,139), but
the activity remained controversial without identification of the gene product. Recently, a paper
submitted for publication from our lab in collaboration with the Stymne lab, in which I am a coauthor, reveals more evidence for GroPCho acyltransferase (GPC AT) activity in plants and in
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yeast (submitted and in revision, Lager et al., 2014). This activity results in acylation of GroPCho
to produce LysoPC, either by transferring an acyl group from an acyl-CoA or from LysoPC,
followed by subsequent acylation to the full lipid, PC, by PLB or Ale1 transacylase activity. The
GPC AT activity is not from PLB activity, but instead from an uncharacterized protein. Studies on
this gene are currently underway in the Patton-Vogt lab in collaboration with the Stymne lab.
Pursuing other functional relationships with the PLB genes, including the Plb3-Lge1
interaction, could provide more complete understanding of the physiological significance of the
PLBs. Lge1 plays a role in ubiquitination of histone H2B in the nucleus, but minimal new
information on Lge1 has been published (140). Moreover, hundreds of physical and genetic
interactions with Lge1 have since been identified making the pursuit of the Lge1-Plb3 interaction
less attractive (yeastgenome.org). Although, the interaction was initially interesting because of the
large cell phenotype, which I thought could correspond to the XL plb123∆ cells we observed.
However, other interactions such as a recently identified interaction between a vacuolar protein,
Mon2, and PLB1, 2, and 3 (141) are of greater interest especially given the results that will be
described in Chapter 4. Briefly, strains bearing deletion of one of the PLB genes displayed altered
vacuolar fragmentation, an effect not observed in mutants with defective PLC or PLD pathways
(141).
In summary, loss of the cell surface associated PLBs and/or utilization of GroPIns causes
alterations in the actin cytoskeleton and an increased cell size. Furthermore, PLB1-3 are regulated
at the transcriptional level by temperature and growth phase in WT yeast. A more in depth
characterization of the PLBs is essential in understanding of the GDTR pathway. Confirmation of
and follow up of the observations presented in this chapter would provide more insight into the
function and purpose of the PLBs in the GDTR pathway and in cellular physiology.
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Chapter 4 Accelerated Plb1-mediated turnover of
phosphatidylcholine upon loss of Ypk1 in S.
cerevisiae
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ABSTRACT
Ypk1, the yeast homolog of the human serum- and glucocorticoid-induced kinase (Sgk1),
affects diverse cellular activities, including sphingolipid homeostasis. We now report that Ypk1
also impacts the turnover of the major phospholipid, phosphatidylcholine (PC). Pulse-chase
radiolabeling reveals that a ypk1∆ mutant exhibits increased PC deacylation and
glycerophosphocholine (GroPCho) production compared to WT. Deletion of PLB1, a gene
encoding a B–type phospholipase that hydrolyzes PC, in a ypk1∆ mutant curtails the increased PC
deacylation. In contrast to previous data, we find that Plb1 resides in the ER and in the medium.
Consistent with a link between Ypk1 and Plb1, the levels of both Plb1 protein and PLB1 message
are elevated in a ypk1∆ strain compared to WT yeast. Furthermore, deletion of PLB1 in a ypk1∆
mutant exacerbates phenotypes associated with loss of YPK1, including slowed growth and
sensitivity to cell-wall perturbation, suggesting that increased Plb1 activity buffers against the loss
of Ypk1. Since Plb1 lacks a consensus phosphorylation site for Ypk1, we probed other processes
under the control of Ypk1 that might be linked to PC turnover. Inhibition of sphingolipid
biosynthesis by the drug myriocin or through utilization of a lcb1-100 mutant results in increased
PLB1 expression. Furthermore, we discovered that the increase in PLB1 expression observed upon
inhibition of sphingolipid synthesis or loss of Ypk1 is under the control of the Crz1 transcription
factor. Taken together, these results suggest a functional interaction between Ypk1 and Plb1 in
which altered sphingolipid metabolism upregulates PLB1 expression via Crz1.
4.1 Introduction
Ypk1, the yeast homolog of the human serum- and glucocorticoid- induced kinase (Sgk1),
is a serine/threonine protein kinase known to affect multiple downstream processes, including lipid
homeostasis (142-146), actin dynamics (147,148), cell wall integrity (147,148), endocytosis
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(144,149), and lipid flippase activity (142). Ypk1 has a functionally redundant homolog, Ykr2.
Either Ypk1 or Ykr2 is required for cell viability, but Ypk1 plays a more prominent role in several
processes (147,150). For example, deletion of YPK1 results in a growth defect and increased
sensitivity to several drugs, phenotypes that are not observed in the ykr2∆ mutant (147). Ypk1, a
cytosolic protein, is recruited to the plasma membrane through its interaction with Slm1/2, proteins
which contain a pleckstrin homology (PH) domain that mediates binding to PI[4,5]P2 (151,152).
At the plasma membrane Ypk1 is first activated by target of rapamycin complex 2 (TORC2)
(151,152) and then by Pkh1/2 phosphorylation (147). TORC2 has been shown to be activated by
sphingolipid depletion (153) and elevated reactive oxygen species (ROS) (154). In turn, Pkh1 and
Pkh2, homologs of the mammalian phosphoinositide-dependent protein kinase-1 (PDK1),
preferentially phosphorylate and activate Ypk1 and Ykr2, respectively, although some crossover
is observed (147). Pkh1 and Ypk1 are localized exclusively to the cytosol, while Pkh2 and Ykr2
also enter the nucleus. Exogenous addition of the long chain base (LCB) phytosphingosine (PHS)
activates Pkh1/Pkh2 in vitro as measured by an increase in PKC phosphorylation (155), while a
more recent paper suggests that the ability of Pkh1/2 to activate Ypk1/2 is unaffected by LCBs,
but instead requires the complex sphingolipid, mannosylinositol phosphorylceramide (MIPC)
(142).
The known targets of Ypk1 phosphorylation, Fpk1/2 (142), Orm1/2 (143), and Gpd1 (156)
are all involved in some aspect of lipid metabolism. Ypk1 phosphorylates and thereby inactivates
Fpk1 and Fpk2, which are upstream activators of the lipid flippase complexes, Lem3-Dnf1 and
Lem3-Dnf2, respectively (142,157). Ypk1 phosphorylation of the endoplasmic reticulum (ER)
transmembrane proteins, Orm1 and Orm2, renders them unable to bind to and inhibit serine
palmitoyl transferase (SPT), the rate-limiting step in sphingolipid biosynthesis (13,143,158).
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Finally, Ypk1 phosphorylates and inactivates Gpd1, glycerol-3-phosphate dehydrogenase, which
reduces dihydroxyacetone phosphate (156). The product of this reaction, glycerol-3-phosphate,
can be shuttled into multiple metabolic pathways, including phospholipid biosynthesis. A
simplified schematic of the Ypk1 signaling pathway is shown in Figure 4-1.

POTENTIAL EFFECTS OF YPK1 DELETION ON PHOSPHOLIPID HOMEOSTASIS:
↑Flippase Activity
= Less PE and PS in outer leaflet of PM
↓SPT activity
= Decreased basal levels of sphingolipids
↓Ceramide Synthesis
= Decreased complex sphingolipids and more sphingosine phosphates
↑Glycerol-3-P
= More flux into PC synthesis

Figure 4-1. Simplified schematic of the Ypk1 signaling pathway and downstream events.
Ypk1/Ypk2 are activated when phosphorylated by the kinases Pkh1 and TORC2. Ypk1/2 phosphorylate
and negatively regulate the flippase activator proteins, Fpk1/2. Fpk1/2 can, in turn, phosphorylate and
negatively regulate Ypk1. Ypk1 phosphorylates Orm1/2, negative regulators of the sphingolipid
biosynthetic genes LCB1/2. Orm1/2 normally binds and inhibits serine palmitoyl transferase so when
Orm1/2 are phosphorylated inhibition is relieved and sphingolipid synthesis can proceed. Ypk1
phosphorylates Gpd1, glycerol-3-phosphate (G3P) dehydrogenase, turning off G3P production. Glycerol 3
phosphate dehydrogenase reduces DHA to glycerol-3-phosphate. G3P can act as a precursor to
phospholipids. Ypk1 phosphorylates and activates Lag1 and Lac1, components of the ceramide synthase
(142,143,146,147,156,159) and unpublished results from the J. Thorner Lab).
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Another finding linking Ypk1 to lipid metabolism is that overexpression of the B-type
phospholipase, PLB1, rescues the lethality of the temperature sensitive ypk1tsykr2∆ mutant (1).
The B-type phospholipases (PLB) catalyze the deacylation of glycerophospholipids to produce the
glycerophosphodiesters and free fatty acids (Fig. 1D). In S. cerevisiae, four genes encode proteins
with PLB activity, PLB1, PLB2, PLB3, and NTE1, which function in membrane remodeling in the
cell. Based on in vivo studies, Plb1 primarily deacylates phosphatidylcholine (PC) to produce
external glycerophosphocholine (GroPCho) (69). Biochemical studies have suggested that Plb1 is
plasma membrane-associated and secreted from the cell (43,45,69), whereas Nte1 is localized to
the endoplasmic reticulum and is responsible for the production of internal GroPCho (103). The
primary substrate for Plb2 appears to be exogenous phospholipids, and Plb3 acts on
phosphatidylinositol (PI) to produce extracellular glycerophosphoinositol (GroPIns) (43,45).
PC synthesis and catabolism are tightly regulated in yeast (9) and other eukaryotic cells
(18), and disruptions to PC metabolism can result in aberrant physiological conditions. In
mammalian cells increased choline uptake and incorporation into PC is a marker for proliferative
growth (160), and conversely, inhibition of choline synthesis results in apoptosis (161). Aberrant
PC levels and/or alterations in GroPCho have also been observed in patients with various cancers,
such as colorectal (162) and prostate (163) cancer, and in Alzheimer’s disease (164,165). What
has remained unknown, however, is how protein kinases and members of the B-type
phospholipases, which deacylate phospholipids to produce GroPCho, are coordinately regulated
to ensure lipid homeostasis. Here, we describe a novel role for Ypk1, the yeast homolog of Sgk1,
in regulating Plb1 mediated PC turnover.
4.2 Experimental Procedures
Strains, plasmids, media, and growth conditions. The S. cerevisiae strains used in this study
are shown in Table 1. Strains were grown aerobically with shaking at 30ºC or 37ºC, as noted.
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Turbidity was monitored by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo
Spectronic spectrophotometer. Empty vectors, YEp351 and pRS426, and vectors overexpressing
each of the PLB genes, YEp351-PLB1, YEp351-PLB2, YEp351-PLB3, and pRS426-NTE1, were
gifts from Susan Henry (YEp351 series) (45) and Chris McMaster (pRS426-NTE1) (166). Media
used for this study included rich yeast extract peptone dextrose (YPD) medium purchased from
Fisher Scientific, or synthetic complete yeast nitrogen base (YNB) medium made as described
previously, but containing 2% glucose and 75 µM inositol (93).
Construction of strains. The S. cerevisiae WT strain BY4742 was purchased from Open
Biosystems (Thermo Scientific, Huntsville, AL, USA). The deletion strains were constructed using
standard homologous recombination techniques (121). Drug resistant markers, hphMX, KanMX,
natMX, and ble were amplified from plasmids pAG32, pUG6, pAG25, and pUG66, respectively,
using the primers listed in Table 2, and the resulting DNA fragments were inserted in place of the
genes targeted for deletion. The plasmids were received from Euroscarf (167,168). For deletion of
YPK1 in the crz1∆ strain, the URA3 cassette was amplified from plasmid pPMY-3xHA (169), and
the resulting DNA fragment was used to disrupt YPK1.
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Table 4.1 S. cerevisiae strains used in this study (Chapter 4)
Strain

Genotype

Source

JPV 399

WT, BY4742

BY4742; MATα his3∆1 leu2∆0 lys2∆0 ura3∆0

JPV 636

ypk1∆

BY4742; ypk1∆::KanMX

JPV 668

plb1∆

BY4742; plb1∆::hph

Research
Genetics
Research
Genetics
This study

JPV 766

ypk1∆plb1∆

BY4742; ypk1∆::KanMX plb1∆::hph

This study

JPV 744

WT PLB1-I-3xHA

BY4742; PLB1-I-3xHA

This study

JPV 745

ypk1∆ PLB1-I-3xHA

BY4742; ypk1::KanMX PLB1-I-3xHA

This study

JPV 671

crz1∆

BY4742; crz1∆::KanMX

JPV 782

crz1∆ypk1∆

BY4742; crz1∆::KanMX ypk1∆::URA3

Research
Genetics
This study

JPV 680

plb123∆nte1∆

This study

YPH 499

WT, YPH499

YES 3

ypk1∆

BY4742; plb1∆::hph plb2∆::KanMX plb3∆::nat
nte1∆::ble
MATa ade2-101och his3∆200 leu2∆1 lys2-801am trp1∆1
ura3-52
YPH499; ypk1-∆1::HIS3

YES 1

ykr2∆

YPH499; ykr2-∆1::TRP1

(147)

ts

ts

(147)
(147)

YPT 40

ypk1 ykr2∆

YPH499; ypk1-1 ::HIS3 ykr2-∆1::TRP1

(147)

JPV 772

plb1∆

YPH499; plb1∆::hph

This study

JPV 773

ypk1∆plb1∆

YPH499; ypk1-∆1::HIS3 plb1∆::hph

This study

ts

YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 plb1∆::hph

This study

ts

YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm1∆::hphNT1

(143)

ts

JPV 774
YFR 276

ypk1 ykr2∆plb1∆
ypk1 ykr2∆orm1∆

YFR 279

ypk1 ykr2∆orm2∆

YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm2∆::URA3

(143)

YFR 283

ypk1tsykr2∆orm1∆orm2∆

(143)

RH 406

WT

YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm1∆::hphNT1
orm2∆::URA3
MATα leu2 trp1 ura3 bar1

RH 3804

lcb1-100

MATα leu2 trp1 ura3 bar1 lcb1-100

ts

(170)
(170)

Table 4.2 Nucleotide sequences of primers used for gene deletions in this study (Chapter 4)
Gene Name
PLB1

Primer
Forward

PLB1

Reverse

CRZ1

Forward

CRZ1

Reverse

YPK1

Forward

YPK1

Reverse

PLB1-I3xHA
PLB1-I3xHA

Forward
Reverse

Sequence 5' - 3'
CAAAACCATGAAGTTGCAGAGTTTGTTGGTTTCTGCTGCAGTTTTGACTTCTC
TAACCAGCTGAAGCTTCGTACGC
AGAGCCTAAATTAGACCGAAGACGGCACTAATGACACTTAAGACACCA
ATAAAAGGCATAGGCCACTAGTGGATCTG
CCATCACAGCAGTTTAGTACGATTATACACTCTGAACGCGAGTAAAACTAGG
TTGTATTTCAGCTGAAGCTTCGTACGC
TACAAGGGAGTGATGCATCTTCTACCACTTTCAGTTTTAAAATGCCTACCAA
GAGCAGCATAGGCCACTAGTGGATCTG
AGTTCCTCTCATATCAACAAACATTAATACAGTTCCTGAAAATGTATTCTTGG
AAGTCAAAGCGAACAAAAGCTGG
ATGTATTCACTAAGTCTATCTAATGCTTCTACCTTGCACCATTGAGCTACCTA
GCTGTTCCTGTAGGGCGAATTGGG
CTAACAGAGAACGTTAACGCTTGGTCACCAAATAACAGTTACGTC
AGGGAACAAAAGCTGG
TTCTCTGACTAAGTTAATATCATCATCACAGGTTACGTTCGCAGGCTGTAGG
GCGAATTGGG

Bolded sequences are homologous to the template plasmids.
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[14C]-Choline labelling and preparation of external, internal, and membrane fractions.
Cells were grown to uniform labeling in YNB medium containing 20 µM choline and 1 µCi/mL
[14C]-Choline Chloride of negligible concentration (Perkin Elmer, NEC141VU250UC or
American Radiolabelled Chemical, ARC 0208). Cells were harvested in log phase, washed free of
excess label, and re-inoculated at OD600 = 0.2 into YNB medium containing 10 mM nonradioactive
choline. At various time points, 1 mL aliquots of the chase cultures were removed and separated
into external, internal, and membrane fractions (93,171).

In brief, cells were pelleted by

centrifugation and the supernatant was removed and retained as the extracellular fraction. The cell
pellet was resuspended in 0.5 mL of 5% trichloroacetic acid (TCA) followed by a 20 minute
incubation on ice. Cells were pelleted again by centrifugation and the supernatant was removed as
the intracellular (soluble) fraction. The pellet was then resuspended in 0.5 mL of 1 M Tris (pH =
8), centrifuged, and the supernatant was added to the intracellular fraction. The final cell pellet
was resuspended in 0.5 mL of 1 M Tris (pH = 8) and saved as the membrane fraction. Total counts
(external + internal + membrane) recovered at each time point as well as the percentages of counts
in each fraction were tracked by liquid scintillation counting (LSC).
Analysis of choline-containing metabolites. The water soluble choline containing
metabolites were separated by anion exchange chromatography (172). Internal and external
samples were diluted 5-fold in deionized H2O, applied to a 250 µL Dowex 50Wx8 200 – 400 anion
exchange column, and eluted as described previously (172). [14C]-GroPCho was eluted with a 1
mL and 2 mL H2O wash. If present, [14C]-choline phosphate was eluted with a subsequent 3 mL
H2O wash. [14C]-choline was eluted with 5 mL of HCl. Standards were used to verify the separation
procedure, and label incorporated into each metabolite was quantified by LSC. To confirm results
by independent methods, [14C]-choline containing metabolites from selected samples were
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separated by TLC using previously published methods (173) and/or by HPLC with an in-line
radioactive detector (65,66). For TLC, samples were dried down, resuspended in 1:1
methanol:H2O, were spotted on Silica plates, and metabolites separated with a mobile phase of
CH3OH:0.6% NaCl:NH4OH (50/50/5, v/v/v).
Phospholipids from the membrane fraction were extracted as described previously (174).
The membrane pellet was resuspended in 1 mL of ESOAK (95% ethanol: diethylether: H2O:
pyridine: NH4OH, 15:5:15:1:0.036) and incubated at 60ºC for one hour. The suspension was
centrifuged and the lipid containing supernatant was extracted with 2.5 mL of
choloroform:methanol (2:1). Low speed centrifugation separated the layers and the bottom layer
containing the glycerophospholipids was dried under N2 and the residue was resuspended in
choloroform:methanol (2:1). Radiolabelled PC and LysoPC were resolved by TLC on Silica Gel
60A (Whatman) plates in chloroform: ethanol: H2O: triethylamine (30/35/7/35, v/v/v/v) mobile
phase (171,175).
Analysis of PC synthesis rate. Strains were grown to log phase (OD600 = 0.5) in YNB 75
µM inositol medium, harvested by centrifugation, and concentrated to equivalent densities in fresh
YNB containing 75 µM inositol and 100 µM choline. To start the assay, 50 µL of 0.005 mCi/mL
[C14]-choline chloride was added and cells were allowed to incubate for 30 minutes at 37°C. The
cells were pelleted by centrifugation, washed with water, and suspended in 0.5 mL of 5% TCA for
10 minutes. After pelleting, the supernatant was discarded and the membrane pellet was washed
with water. Lipids were extracted from the remaining pellet as described above. Incorporation of
[C14]-choline chloride into PC was quantified by LSC and verified by TLC.
LC-MS analysis of extracellular choline and GroPCho. Cells were grown in YNB medium
containing 75 μM inositol, 20 μM choline, and 2 mM KH2PO4 instead of 7 mM KH2PO4. The cells
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were pelleted by centrifugation at 1,600 x g for 3 minutes and the supernatant containing the
extracellular metabolites was filtered through 0.2 µM cellulose acetate filters. The method of
analysis for these extracellular metabolites by mass spectrometry was described previously
(104,176). A 250 µL aliquot of supernatant was spiked with an internal standard (choline-d9) and
water soluble lipid metabolites were extracted by addition of 2.25 mL of cholorform:methanol
(2:1, v/v). The suspension was agitated with a Vortex mixer followed by centrifugation for 3
minutes at 1,600 x g. The upper aqueous phase was dried under N2 and resuspended in 125 μL of
acetonitrile:methanol (75:25, v/v) with 10 mM ammonium acetate, pH 4.5. After centrifugation at
16,000 x g for 10 minutes, an aliquot of the supernatant was transferred to a LC vial and diluted
20-fold in acetonitrile:methanol (75:25, v/v). A 10 µL volume was injected into the Agilent 1200
series Rapid Resolution LC system coupled to an Agilent 6440 Triple Quadrupole Mass
Spectrometer. Separations were performed on a Waters Xbridge HILIC (150×4.6 mm, 5 μm)
column with an isocratic elution at a flow rate of 0.5 mL/min at room temperature. The mobile
phase was acetonitrile/water (70:30 v/v) with 10 mM ammonium acetate. Electrospray mass
spectrometry (ESI-MS) was performed with the scan mode set to multiple reaction monitoring
(MRM) targeting GroPCho (258.0 104.0), choline (104.1  60.1), and choline-d9 (113.1 
69.1) in fast switch ionization mode. The MS parameters were set as previously optimized: 10eV
collision energy, 3.5 kV capillary voltage, 50 V fragmentor voltage, 200 ms dwell time, 300ºC
drying gas temperature, and 325ºC sheath gas temperature. Sheath gas flow and drying gas flow
rates were 10 and 8 L/min respectively. Each sample was run in duplicate. Data were acquired and
analyzed using MassHunter Work Station software. The peak areas of the target metabolites were
normalized to the internal standard and to the density of cells (OD600) from which metabolites were
extracted.
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RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in
YNB medium containing 75 µM inositol under the conditions specified in the text. RNA was
extracted using a hot phenol-chloroform extraction (99). A 7 µg sample of RNA was DNase treated
with 2 units of DNase at 37ºC for 30 minutes using the TURBO DNA-free™ Kit (Applied
Biosystems) per the manufacturer’s specifications. Message abundance was quantified by
quantitative reverse transcriptase PCR (qRT-PCR) using the Verso™ SYBR® Green 1-Step QRTPCR ROX Kit (Thermo Scientific) on the Applied Biosystems StepOnePlus Real Time PCR
System. The primers used are shown in Table 4.3. Standard curves for each primer pair were
optimized to determine acceptable primer concentrations (70-100 nM) and template concentrations
(15-25 ng/25 µL reaction). Reverse transcription was carried out at 50C for 15 minutes followed
by 95C for 15 minutes for RT inactivation and polymerase activation. Amplification parameters
were 40 cycles at 95C 15s, 54.5C 30s, and 72C 40s. Primer specificity was verified by melt
curve analysis and visualization of amplicons by gel electrophoresis. Primer sets did not produce
amplicons when RNA from the respective deletion strains was used as template. No template
control (NTC) and minus reverse transcriptase (-RT) reactions were performed to verify the
absence of genomic DNA contamination in the RNA samples and/or the reagents. RNA from at
least three independent cultures of all strains was analyzed in triplicate reactions per primer set.
Data were normalized to the endogenous control gene, SNR17, and analyzed using the comparative
∆∆CT approach (100,101).
Table 4.3 Nucleotide sequences of primers used for qRT-PCR
Gene Name

Primer

Sequence 5' - 3'

SNR17

Forward

TTG ACT CTT CAA AAG AGC CAC TGA

SNR17

Reverse

CGG TTT CTC ACT CTG GGG TAC

PLB1

Forward

GCA TAC ACC AAG GAG GCT TTG

PLB1

Reverse

GAG TGG ATA GCA AGG AAG TGT CAC
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Construction of the chromosomal PLB1-I-3xHA allele. The plasmid pPMY-3xHA (169),
kindly provided by Nancy Hollingsworth (Stony Brook University), was used as the template to
amplify a 3xHA-URA3 module for insertion into the genome between amino acids 30 and 31 of
Plb1. Because Plb1 is predicted to be GPI anchored to the plasma membrane, insertion at this point
would avoid cleavage of the HA tag from either end since both the N-terminal localization signal
and C-terminal GPI anchor attachment site are cleaved during processing and GPI anchor
attachment. Insertion did not interfere with the predicted catalytic site for Plb1. The primers used
to amplify the 3xHA-URA3 module are listed in Table 4.2. The PCR product was transformed into
WT and ypk1∆ strains and transformants were selected on YNB plates lacking uracil. To verify
integration at the correct location DNA was extracted and used as template with two sets of
primers. Verified transformants were grown in YPD liquid medium to allow for recombination
and loss of the URA3 marker. Cells that had lost the URA3 marker were selected on YNB plates
containing 5-FOA. DNA was extracted from the 5-FOA resistant colonies and used as a template
for PCR. Strains producing the expected amplicon size, indicating insertion of the 3xHA and loss
of the URA3, were named JPV 767 (WT + PLB1-I-3xHA) and JPV 745 (ypk1∆+ PLB1-I-3xHA).
These strains therefore contain DNA encoding an internal 3xHA tag between nucleotides 90 and
91 of PLB1 in their genomic DNA. The function of Plb1 containing the 3xHA tag was verified by
observing the expected Plb1 activity in PC turnover/GroPCho production experiments.
Protein extraction and sucrose gradient separation. For total protein extraction from cell
lysates, cultures were grown in YNB+75 µM inositol medium to log phase (OD600 ≈ 0.7). Cells
were collected by centrifugation of a 125 mL culture and the supernatant was removed for
evaluation of secreted protein. The supernatant was concentrated 100-fold using an Amicon Ultra
30K centrifugal filter (Millipore). The cell pellet was resuspended in 200 µL SUME protein lysis
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buffer (1% SDS, 8 M urea, 10 mM MOPS, 10 mM EDTA, 1 mM AEBSF, 1X Yeast/Fungal
Protease Arrest™ G-biosciences 786-333), and lysed with glass beads by eight 1-minute alternate
cycles of agitation on a Vortex mixer and incubation on ice. Centrifugation at 2000 x g for 5
minutes removed unbroken cells and debris. Protein concentration in the concentrated supernatant
and the cell lysate was determined by Bradford assay kit (Thermo Fisher).
Sucrose gradient separation was performed as described (177,178). A 100 mL culture was
grown to log phase and 2 mL of 0.5 M NaN3 was added at time of harvest. The cells were collected
by centrifugation and broken by glass bead lysis in a 10mM Tris-HCl, pH 7.5, 1mM EDTA, 10%
sucrose solution. Cell lysates were cleared of debris by low speed centrifugation and the resulting
lysate was layered onto an 11 mL gradient of 30-70% sucrose in the lysis buffer. The gradient was
centrifuged at 100,000 x g in a Beckman SW41 rotor for 18 hours at 4ºC. One mL fractions were
collected from the top of the gradient by pipetting. Proteins of interest were analyzed by SDSPAGE and Western blot analysis.
Western blot analysis. Total protein extracts were analyzed by SDS-PAGE and Western
blotting. Equal amount of protein was loaded onto NuPAGE Bis-Tris gels (Invitrogen, IM-8042)
and transferred to a nitrocellulose membrane using the XCell Blot Module (Invitrogen).
Membranes were incubated in blocking buffer (phosphate buffered saline (PBS) containing 5%
casein in 0.1M NaOH, 5% BSA, phenol red, and NaN3) for 30 minutes at room temperature.
Primary antibody against HA-Plb1 (monoclonal antibody HA-11, Covance catalog number MMS101P) was added to the solution at a 1:10,000 dilution and incubated overnight at 4ºC. Primary
antibody was removed and the membrane was washed in PBS. The membrane was incubated in
blocking buffer, without NaN3, containing a 1:125,000 dilution of secondary antibody (HRPlabeled affinity–purified antibody to mouse IgG (H+L), KPL catalog number 074-1806) for 1 hour
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at room temperature. The membrane was washed in PBS and incubated with SuperSignal West
Femto extended duration substrate reagent (Peirce, #34095) before exposure on either a Kodak
440CF Image Station or exposure to Kodak Biomax MR Film for visualization.
Sucrose gradient fractions were analyzed by SDS-PAGE and Western blot analysis as
described for total protein extracts, but equal volumes of each fraction were run on the SDS-PAGE
gel instead of equal amounts of protein. Membranes were probed with primary antibodies against
HA-Plb1, Sec61 (1:1,000), and Pma1 (1:4,000).

Anti-Pma1 was provided by Dr. Carolyn

Slayman, Yale University, and anti-Sec61 was obtained as described (179). The blots were then
incubated with the appropriate secondary antibody, HRP-conjugated anti-rabbit or HRPconjugated anti-mouse. For quantification of Western blots, densitometry was carried out using
the Kodak 1D software.
Statistical Analysis. GraphPad Prism was used for statistical analysis by Student’s t – test or
ANOVA as indicated.

4.3 Results
4.3.1 Plb1 mediated extracellular GroPCho production increases upon loss of YPK1.
Plb1 deacylates phosphatidylcholine to produce free fatty acids and extracellular
glycerophosphocholine (GroPCho) (69) (Figure 4-2 C). To better define the link between Ypk1
and Plb1 activity, turnover of phosphatidylcholine (PC) and the concomitant production of the
GroPCho were examined. Cells grown to uniform labeling with C14-choline chloride were washed
free of label and re-inoculated into fresh medium containing 10 mM choline at 37°C. The chase
was performed at elevated temperature to maximize turnover, since the Ypk1 pathway is activated
by heat stress (11,142) and because PLB1 expression is upregulated by elevated temperature (see
Figure 4-5a). These experiments were performed in both the BY4742 and YPH499 backgrounds
because of slight differences in phenotypes observed in ypk1∆plb1∆ double mutants constructed
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in the two backgrounds, as described below. At the indicated times, cells were harvested, the
percentages of the total radioactivity in the extracellular, intracellular, and membrane fractions
were determined, and the metabolites produced were identified. Radioactivity in the extracellular
fraction, which is used to monitor in vivo Plb1 activity, consisted of C14-GroPCho and free C14choline. As shown in Figure 4-2, deletion of YPK1 resulted in increased production of extracellular
GroPCho that is ameliorated by deletion of PLB1. This held true for both strain backgrounds,
although the magnitude of the change varied from nearly 3-fold for YPH499 to roughly 5-fold for
BY4742. The rest of the counts at each time point were in either the membrane or the intracellular
fraction (Table 4.4).
Examination of the intracellular fractions revealed there is a decrease in internal GroPCho
production in both the ypk1∆ and the ypk1∆plb1∆ strains (Table 4.4). Internal GroPCho production
occurs primarily through Nte1 mediated turnover (103), suggesting that there may be a trade-off
between Nte1 and Plb1 activity upon loss of Ypk1. Loss of Ypk1 also appears to cause increased
extracellular choline. The phospholipase D (PLD) that hydrolyzes PC into free choline and
phosphatidic acid (180), Spo14, could be responsible for the increase. Although quantitative
differences in the levels of choline metabolites were observed as a function of strain background,
the general trends were consistent. Also, deletion of YKR2, the paralog of YPK1, did not affect
GroPCho production (Figure 4-2 B).
To confirm the results obtained through radiolabeling, and to obtain a more complete
picture of the extracellular choline metabolites produced, we performed tandem mass spectrometry
(LC-MS/MS). Through radiolabeling, we were able to monitor the turnover of Kennedy pathwayderived PC synthesized during the labeling period. Through MS, we could monitor all GroPCho
produced during the experiment through both the PE methylation pathway and through the
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Kennedy pathway (9). Importantly, the MS data confirmed that GroPCho production rose upon
deletion of YPK1, and that Plb1 plays a major role in mediating the increase (Figure 4-2 C). Using
MS, we also detected a decrease in extracellular GroPCho production by plb1∆ yeast as compared
to WT cells that was not apparent through pulse-chase radiolabelling. As indicated by both the MS
data and the radiolabeling data, Plb1 cannot be the only phospholipase responsible for extracellular
GroPCho production, as strains lacking Plb1 still produce GroPCho. In fact, a strain in which all
of the known PLBs are deleted, plb123∆ nte1∆ exhibits greatly reduced, but not completely
eliminated GroPCho production (Figure 4-2 C), suggesting that one or more deacylating
phospholipases have yet to be identified.
4.3.2 Turnover of another glycerophospholipid, phosphatidylinositol, is unaffected by
deletion of YPK1.
In a WT strain, GroPIns produced through the Plb3-mediated deacylation of PI is the major
phospholipid metabolite found in growth medium (45). To monitor this metabolite, WT and ypk1∆
cells grown to uniform labeling with [H3]-inositol were chased with non-radiolabelled inositol,
similar to the conditions used in the C14choline labeling experiments above. However, we observed
no significant difference between WT and ypk1∆ strains in the rate of PI turnover or in the
percentage of water soluble inositol-containing counts found in extracellular (WT 31% ± 1 and
ypk1 25% ± 2) or intracellular (WT 22% ± 1 and ypk1 26% ± 3) fractions following a 5-hour
chase.
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Figure 4-2. Plb1-mediated extracellular GroPCho production is increased upon deletion of
YPK1.
A and B, Strains in the BY4742 (A) and YPH499 (B) backgrounds were pre-grown at 30⁰C in YNB medium
containing 0.2 Ci/mL [14C]-Choline chloride, followed by a chase at 37⁰C in YNB medium containing 10
mM choline. Extracellular, intracellular, and membrane fractions were isolated, and [ 14C]-cholinecontaining metabolites from extracellular fractions were separated by anion exchange column
chromatography. Values are the means ± S.E. of triplicate cultures and are representative of multiple
experiments. One-way ANOVA was performed indicating a significant difference between GroPCho
produced in the ypk1∆ strain compared to GroPCho produced by each of the other strains listed (A, p ≤
0.011; B, p ≤ 0.015). C, Cells grown to log phase were harvested and the extracellular medium analyzed
for GroPCho by LC-MS. Relative abundance is normalized to OD600 and to the internal standard. Values
are the means ± S.E. of at least two independent cultures. D, Plb1 mediated deacylation of PC to GroPCho.
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Table 4.4 Cell Associated Counts from Figure 4.1
A. Cell Associated Counts in BY4742 (% of total counts)
Time,
Internal
Internal
Membrane
Strain
hours
Choline
GroPCho
PC
WT
plb1∆
ypk1∆
ypk1∆ plb1∆

0

2±0

34 ± 1

58 ± 3

94

4

2±0

81 ± 1

10 ± 0

93

0

1 ±0

38 ± 1

61 ± 3

99

4

1 ±0

76 ± 1

15 ± 1

92

0

1 ±0

31 ± 1

66 ± 3

98

4

1 ±0

50 ± 4

18 ± 2

69

0

1±0

35 ± 3

57 ± 4

92

4

1±0

55 ± 3

24 ± 1

80

B. Cell Associated Counts in YPH499 (% of total counts)
Time,
Internal
Internal
Membrane
Strain
hours
Choline
GroPCho
PC
WT
plb1∆
ypk1∆
ypk1∆ plb1∆

Total
Counts

Total
Counts

0

0 ± 0.2

7±1

90 ± 1

97

4

2 ± 0.4

14 ± 2

62 ± 2

82

0

2±1

13 ± 1

82 ± 1

97

4

1 ± 0.1

9±4

63 ± 1

82

0

2±1

11 ± 1

84 ± 1

97

4

2 ± 0.2

10 ± 2

53 ± 7

69

0

3±1

15 ± 2

80 ± 3

98

4

3 ± 0.5

8±2

68 ± 3

70

* Values for the internal and membrane metabolites are derived
from the experiments described in Figs. 1A and 1B.
4.3.3 PC Synthesis via the Kennedy pathway is unaffected by loss of YPK1.
Since an increased rate of PC deacylation and GroPCho production was observed upon loss
of Ypk1, we next tested if the rate of PC synthesis was affected. The logic underlying this
experiment was that Cki1 (choline kinase) and Pct1 (cholinephosphate cytidylyltransferase), both
of which are involved in PC synthesis by the Kennedy pathway, contain potential consensus Ypk1
phosphorylation sites [R-x-R-x-x-S/T-ϕ where ϕ is a preference for hydrophobic amino acids
(150)]. To detect changes in synthesis rate via the Kennedy pathway, we measured the
incorporation of [C14]-choline into PC following a 30 minute pulse, but no difference was found
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between WT and ypk1∆ yeast (Figure 4-3). This result also suggests that choline uptake was not
significantly affected by loss of Ypk1.

[C14]-choline incorporation
into PC (pmol/min/OD600)

12000

8000

4000

0

WT

ypk1

Figure 4-3. Synthesis of PC is not altered upon loss of Ypk1.
WT and ypk1∆ strains in the BY4742 background were grown to log phase, harvested, and resuspended to
equal densities in YNB medium. [C14]-choline was added and the amount of incorporation into PC after 30
minutes was determined. Values are the means ± S.E. of three independent cultures assayed in duplicate.
Similar results were observed in the YPH499 background (data not shown).

In contrast, the Plb1 sequence lacks the Ypk1 consensus phosphorylation site. Furthermore,
Plb1 was shown to have a low likelihood value for phosphorylation by Ypk1 in a large-scale
peptide screen for kinase activity (181). Similarly, the Plb1 sequence does not contain the Fpk1
phosphoacceptor site, RxSLD(x)15-21RxSLxD (142). Thus, direct regulation of Plb1 through
phosphorylation by Ypk1 or its downstream kinase, Fpk1, is unlikely. In addition, a strain bearing
deletion in FPK1 did not significantly alter GroPCho production. The percentages of total [C14]choline label incorporated into external GroPCho in the fpk1 and WT strains following an eight
hour chase, were 8 ± 1% and 5 ± 1%, respectively. Together, these data strongly suggest that Fpk1
is not involved in the regulation of Plb1 by Ypk1.
4.3.4 The secreted and cell associated forms of Plb1 increase in a ypk1∆ strain.
Plb1 activity has been reported in plasma membrane fractions, in the periplasm, and in the culture
supernatant (45,69). However, localization data were absent in large-scale analyses using fluorescent tags
fused to the C-termini of yeast ORFs expressed under control of their endogenous promoters (71-75), and
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in a study utilizing C-terminal fusions to an epitope tag with the target genes expressed under control of the
GAL promoter (76). In addition, a localization screen of proteins involved in lipid metabolism in which
Plb1 was C-terminally tagged and expressed under the control of the TEF promoter, demonstrated ER and
vesicle localization, but plasma membrane localization was not apparent; the medium/secreted fraction was
not analyzed in this study (77). Complicating the question of Plb1 localization is that it has a predicted GPIanchor, which should lead to plasma membrane residence (78,182). During processing, GPI-anchored
proteins are cleaved just after the anchor attachment site, which removes the C-terminus (22). Therefore, if
Plb1 were GPI-anchored, C-terminal tagging—as used in several of the studies cited above—would be
unable to detect the final processed protein.

To establish the localization of Plb1, and to have a reliable epitope-tagged Plb1 for Western
analysis, we constructed a WT and ypk1∆ strain in which HA was inserted into the genomic copy
of PLB1 near the N-terminal end, after the signal sequence, but before the catalytic site. This PLB1I-3xHA construct was judged functional by confirming that ypk1∆ containing PLB1-I-3xHA
displayed elevated GroPCho production indistinguishable from the ypk1∆ strain (see
“Experimental Procedures”; data not shown). Consistent with increased GroPCho production,
ypk1∆ containing the PLB1-I-3xHA allele displayed greater Plb1 abundance in total cell lysates
and in the medium as compared to the WT strain ( Figure 4-4 A and B). To examine intracellular
localization, we performed sucrose gradient fractionation using lysates from WT strains that
contained the integrated, functional PLB1-I-3xHA gene. Interestingly, we found Plb1 associated
with the ER (as indicated by co-migration with Sec61), as expected for a protein trafficking
through the secretory pathway, but the protein was absent from plasma membrane fractions, as
indicated by the migration of Pma1 (Figure 4-4C). These results, which are consistent with fluorescence
microscopy of C-terminally tagged Plb1 under the control of the TEF promoter (77), lead us to conclude
that the protein is not plasma membrane associated, and that if it is GPI-anchored, it is efficiently released
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from the plasma membranes under the conditions used here. We suspect that the cell surface-associated
Plb1 activity that releases GroPCho into the medium is due to its periplasmic localization.

Figure 4-4. Plb1 protein abundance and localization.
A, WT and ypk1∆ yeast containing the PLB1-I-3xHA allele were grown in YNB medium at 30⁰C to log
phase. The supernatant was concentrated 100-fold, and total protein was extracted from the cells. Western
blot was performed on both fractions using an anti-HA-Plb1 primary antibody and HRP-conjugated antimouse secondary. GAPDH was used as a loading control for the lysate fractions. B, Amount of Plb1 protein
was quantified by densitometry of western blots and normalized to the culture density (OD600) and sample
volume. Values represent the fraction of total Plb1 protein in the WT strain. C, WT yeast containing PLB1I-3xHA were grown in YNB medium, lysed, and subjected to sucrose gradient centrifugation. The gradient
was fractionated and the migration of Plb1 and the indicated marker proteins, Pma1 (plasma membrane)
and Sec61 (ER), were determined by SDS-PAGE and Western blot analysis. Fraction number 1 on the left
represents the top of the gradient.

Although Plb1 is predicted to be 72 kDa, the species found in the lysate migrates at about
145 kDa. While the 145 kDa band is the most abundant band in the medium, a less abundant,
diffuse band around 260 kDa is also present. Plb1 is known to be N-glycosylated (183,184), and
multiple glycosylated forms of secreted phospholipase B have been detected previously
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(69,185,186). Upon treatment with Endo Hf, the protein migrates as one band at approximately 72
kDa (data not shown).
4.3.5 Compromised sphingolipid synthesis upregulates PLB1 expression and increases PC
turnover.
Consistent with the observed increases in PC deacylation and Plb1 abundance (Figure 4-2
and Figure 4-4), PLB1 transcript levels also increased upon loss of YPK1 at both 30°C and after a
37°C temperature shift (Figure 4-5 A). In both WT and ypk1∆ yeast, a shift to 37°C increased PLB1
message levels. The ypk1∆ strain in the YPH499 background displayed a similar trend (data not
shown).
The major role for Ypk1 described in the literature is the regulation of sphingolipid
homeostasis (143). If the mechanism by which loss of Ypk1 upregulates Plb1 expression involves
compromised sphingolipid synthesis, we would expect reduction of sphingolipid synthesis by
other means to have a similar effect on Plb1 expression. Indeed, PLB1 expression was elevated in
a WT strain treated with either myriocin or aureobasidin (Figure 4-5 B and C), which inhibit SPT
and inositolphosphoceramide (IPC) synthase, respectively (187,188) (Figure 4-5 D). We also
monitored PC turnover in WT cells treated with myriocin, and saw the expected increase in
external GroPCho production (Figure 4-5E). Similar trends were observed in a YPH499 strain
background. Sphingolipid synthesis can also be diminished genetically through the use of the
lcb1-100 strain, which harbors temperature-sensitive SPT activity (170). As anticipated, the lcb1100 strain shifted to the restrictive temperature also exhibited increased PLB1 expression as
compared to WT (Figure 4-5F).
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Figure 4-5. PLB1 message levels are elevated by heat stress and upon disruption of
sphingolipid homeostasis.
A, Strains in the BY4742 background were grown to early log phase in YNB medium at 30°C. Cultures
were split and incubated at 30⁰C or 37⁰C, as indicated, for 3 hours. B, Cells were grown in YNB medium
at 30°C to an OD600 ≈ 0.7, myriocin (dissolved in methanol) was added to a final concentration of 1 µg/mL,
and cultures were incubated for 2 hours at 30°C. C, Cells were grown in YNB medium at 30°C to an OD600
≈ 0.4, aureobasidin (dissolved in methanol) was added to a final concentration of 1 µg/mL and the cells
were incubated for 3 hours at 30°C. A-C, At harvest, total RNA was extracted and PLB1 transcript levels
were analyzed by real-time qRT-PCR using the comparative CT method. Data were normalized to the
amount of the endogenous control mRNA, SNR17, and expressed relative to the value in WT control cells.
Values represent the means ± S.E. of at least 3 independent cultures assayed in triplicate. D, Simplified
schematic of sphingolipid synthesis in S. cerevisiae including targets of inhibiting drugs. E, WT cells in the
BY4742 background were pre-grown at 30⁰C in YNB medium containing 0.2 Ci/mL [14C]-Choline
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chloride, followed by a chase at 30⁰C in YNB medium containing 10 mM choline and 1 g/mL myriocin
in methanol or an equivalent volume of methanol. Extracellular, intracellular, and membrane fractions were
isolated, and [14C]-choline containing metabolites from extracellular fractions after 3 hours were separated
by anion exchange chromatography. Values are the means ± S.E. of at least duplicate cultures and are
representative of multiple experiments. Similar trends were observed in the YPH499 background (data not
shown). F, The lcb1-100 and WT strains were grown in YNB medium at room temperature (25°C) to an
OD600 ≈ 0.4, then shifted to the restrictive temperature, 37°C, for 90 minutes. RNA was extracted and
analyzed as in A-C. Student’s t-test was performed for statistical analysis (B, p = 0.05; C, p = 0.008; F, p
= 0.0006).

4.3.6 Crz1 mediates PLB1 upregulation either when sphingolipid biosynthesis is
compromised or when Ypk1 is absent.
A recent microarray study showed that many of the up/down regulated genes — including
PLB1 — identified in a ypk1∆ykr2∆ strain bearing an analogue inactivated allele of YPK1 (YPK1as)
contain binding sites for the Crz1 transcription factor (151,152). Thus, we examined the role of
Crz1 in mediating PLB1 expression in response to altered sphingolipid biosynthesis or when YPK1
is deleted. A ypk1∆ mutant exhibited increased PLB1 message levels as compared to WT yeast,
while PLB1 message levels were unchanged in a ypk1∆crz1∆double mutant (Figure 4-6 A). In
addition, upregulation of PLB1 expression in response to myriocin treatment (Figure 4-5 B)
observed in a WT strain did not occur in the crz1 strain (Figure 4-6 B). This data indicates that
Crz1 is required for the upregulation of PLB1 expression that occurs upon loss of Ypk1.
4.3.7 Ameliorating disrupted sphingolipid synthesis by deletion of ORM1 and ORM2 in a
ypk1∆ strain partially rescues PLB1 expression to WT levels.
A primary mechanism by which Ypk1 regulates sphingolipid synthesis is through
phosphorylation of Orm1 and Orm2 (13,189). Orm1 and Orm2 are ER transmembrane proteins
that regulate sphingolipid biosynthesis by binding to and inhibiting SPT (13,158). Upon
phosphorylation by Ypk1, the interaction between Orm1/2 and SPT is lessened, and sphingolipid
biosynthesis is upregulated. Thus, if Ypk1 regulates Plb1 via an Orm1/2 dependent effect on
sphingolipid synthesis, we would expect PLB1 expression to mirror WT levels in a
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ypk1tsykr2∆orm1∆orm2∆ strain grown at the restrictive temperature. In fact, we found that deletion
of ORM1/2 only partially reduced PLB1 expression compared to the ypk1tsykr2∆ strain (Figure
4-7). These results suggest that Ypk1 regulates sphingolipid synthesis via a mechanism that is
partially independent of Orm1/2 phosphorylation.
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Figure 4-6. Crz1 mediates PLB1 upregulation either when sphingolipid biosynthesis is
compromised or when Ypk1 is absent.
A, Strains (BY4742) were grown in YNB medium at 30°C to an OD600 ≈ 0.7 (log phase). An aliquot was
diluted to an OD600 ≈ 0.2 and grown for 3 hours at 37°C. B, WT and crz1 strains were grown in YNB
medium at 30°C to an OD600 ≈ 0.7, myriocin (dissolved in methanol) was added to a final concentration of
1ug/mL, and incubated for 3.5 hours at 30°C. A and B, RNA was extracted and PLB1 message levels were
analyzed by qRT-PCR using the comparative CT method. Data were normalized to the amount of the
endogenous control mRNA, SNR17, and expressed relative to the value in WT cells grown at 30ºC (A) and
WT cells grown with vehicle, methanol (B). Values represent the means ± S.E. of 3 independent cultures
assayed in triplicate. Student’s t-test was performed for statistical analysis, p ≤ 0.0001.

Normalized Fold
Expression of PLB1

5
*

4
3
2
1
0

WT

ypk1

ypk1ts
ykr2

ypk1tsykr2
orm1orm2

Figure 4-7. Deletion of ORM1 and ORM2 in a ypk1 strain partially reduces PLB1
expression. Cells were grown in YNB medium at 30ºC to early log phase followed by a shift to 35ºC
for 1.5 hours. Total RNA was extracted and PLB1 transcript levels were analyzed by real time qRT-PCR
using the comparative ∆∆CT method. Data were normalized to the amount of the endogenous control
mRNA, SNR17, and expressed relative to the value in WT cells. Values represent the means ± S.E. of 3
independent cultures assayed in triplicate. Student’s t-test was performed for statistical analysis, p ≤ 0.04.
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4.3.8 Overexpression of only PLB1 rescues ypk1tsykr2∆ lethality at the restrictive
temperature.
Plb1 was previously identified as a multicopy suppressor of lethality in the ypk1tsykr2∆
strain at the restrictive temperature of 37°C (147). To determine if rescue was PLB1-specific or
could be conferred by other PLB-encoding genes, growth was monitored in the ypk1tsykr2∆ strain
overexpressing PLB1, PLB2, PLB3, or NTE1. The genes were expressed from their endogenous
promoters on multicopy plasmids (see “Experimental Procedures”). Even though there was a 200300-fold increase in PLB1, PLB2, and PLB3 message levels and a 50-fold increase in NTE1
message levels, only overexpression of PLB1 rescued ypk1tsykr2∆ lethality at the restrictive
temperature (Figure 4-8).

Figure 4-8. Overexpression of only PLB1 rescues the lethality of the ypk1tsykr2 strain at
restrictive temperature.
A. WT and ypk1tsykr2 strains (YPH499) harboring the indicated plasmids were pre-grown in selective
medium, harvested, and resuspended to equivalent densities. Cells from 5-fold serial dilutions of each
culture were spotted onto selective medium and grown for 3 days at the permissive (30⁰C) and restrictive
(35⁰C) temperatures.
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4.3.9 Deletion of both PLB1 and YPK1 leads to synthetic interactions.
Based on the data presented in Figure 4-8, PLB1 and YPK1 appear to genetically interact.
To confirm this hypothesis, we examined specific phenotypes in strains lacking both genes. As
shown in Figure 4-9A, a negative genetic interaction was observed between YPK1 and PLB1 when
growth was monitored, although the severity of the defect varied somewhat depending upon the
genetic background employed. On solid YNB medium, ypk1∆plb1∆ isolates constructed in both
the BY4742 or YPH499 backgrounds displayed a growth defect as compared to ypk1∆ at 30ºC and
35ºC (Figure 4-9 A). The ypk1∆plb1∆ strain constructed in the YPH499 background also exhibited
a growth defect on YPD plates (Figure 4-9B).
The Ypk1 pathway influences several downstream events, including cell wall integrity
(147,148). Therefore, we examined the effect of the cell wall perturbing agent, calcofluor white,
on growth. A ypk1∆plb1∆ mutant exhibited increased sensitivity to calcofluor white as compared
to ypk1∆ (Figure 4-9B). This result was most striking in the YPH499 background, where no growth
was observed in the ypk1∆plb1∆ strain in the presence of calcofluor white when present at a final
concentration of 8.5 µg/ml. These findings, together with the fact that PLB1 is a multicopy
suppressor of the lethality of the ypk1tsykr2∆ strain, indicate that increased PC turnover via Plb1
activity increases the fitness of yeast when Ypk1 is absent. More generally, these findings suggest
that sphingolipid synthesis is coordinated with PC turnover to maintain optimal lipid homeostasis.
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Figure 4-9. The slowed growth phenotype and sensitivity to the cell wall perturbing agent,
calcofluor white, in a ypk1 strain is exacerbated by deletion of PLB1.
A, Strains in the BY4742 and YPH499 backgrounds were pre-grown in YNB medium, harvested, and
resuspended to equivalent densities. Cells from 5-fold serial dilutions were spotted onto YNB plates and
incubated for 48 (BY4742) or 32 hours (YPH499). C and D, WT and deletion strains were pre-grown in
YNB medium, harvested, and resuspended to equivalent densities. 5-fold (BY4742) or 10-fold (YPH499)
dilutions were spotted onto YPD and YPD + 8.5g/mL calcofluor white plates and incubated at 30⁰C for
32 or 48 hours, respectively. Data displayed is representative of multiple experiments.
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4.4 Discussion
PC is the most abundant glycerophospholipid in eukaryotic membranes and its synthesis
and catabolism are highly regulated. In yeast, the known routes of PC catabolism occur through
the action of the phospholipase D encoded by PLD1/SPO14 (180), the ER localized PLB encoded
by NTE1 (103), and PLB1 (69). Here we show that Plb1 activity (Figure 4-2) and expression
(Figure 4-5, Figure 4-6) were modulated by the serine/threonine kinase Ypk1. Furthermore, we
show that regulation occurs via a mechanism in which the cell can detect compromised
sphingolipid biosynthesis (Figure 4-6). Blockage of SPT activity through use of an lcb1-100
mutant or by treatment with myriocin also results in increased PLB1 expression. Treatment of cells
with aureobasidin A, which blocks downstream steps in the sphingolipid biosynthetic pathway,
led to a similar effect, indicating that the formation of the complex sphingolipid, IPC, at a
minimum, is required to regulate PLB1 (Figure 4-6).
Plb1 has been widely accepted as a secreted and plasma membrane-associated protein
based on cellular fractionation studies and its role in the production of extracellular GroPCho (69).
Our results, utilizing a Plb1 construct with an internal HA tag to account for a potential GPI anchor,
indicate that Plb1 is secreted (Figure 4-5A) and fractionates with the ER marker, Sec61, but not
with the plasma membrane marker, Pma1 (Figure 4-5C). As a secreted and glycosylated protein,
it is not unexpected to find Plb1 at the ER. However, our data along with that of others suggest the
intriguing possibility that Plb1 may be active intracellularly as well as at the cell surface, since it
has been shown to metabolize excess intracellular lysophospholipids (190) and to be involved in
PC acyl chain remodeling (191). The secreted/periplasmic form of Plb1 is most likely responsible
for the production of extracellular GroPCho. Notably, extracellular GroPCho is not a dead-end
metabolite, but can be recycled into PC synthesis following its uptake via glycerophosphodiester
transporters that have been identified in both S. cerevisiae (61) and C. albicans (104,106).
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Ypk1 regulates sphingolipid synthesis by phosphorylating Orm1/2 (143). Phosphorylated
Orm1/2 cannot bind to SPT, resulting in upregulated sphingolipid synthesis. However, our results
show that the increase in PLB1 expression observed in a ypk1∆ strain is not entirely mediated by
Orm1/2,

since

PLB1

transcript

levels

are

not

depressed

to

WT

levels

in

the

ypk1tsykr2∆orm1∆orm2∆ strain (Figure 4-8). This result suggests that Ypk1 may affect
sphingolipid synthesis via a mechanism that goes beyond regulation of Orm1/2 activity.
Alternately, deletion of Orm1/2 may have additional consequences that impinge upon Plb1
expression and phospholipid metabolism. For example, an orm1∆orm2∆ strain is an inositol
auxotroph, indicative of disrupted regulation of phospholipid metabolism (158). Furthermore,
auxotrophy can be reversed by growth in the presence of myriocin, indicating a connection
between sphingolipid and phospholipid metabolism upon loss of Orm1/2 (158). These data
suggest a complicated relationship between Orm1/2 and its role in regulating sphingolipid and
phospholipid metabolism.
Phosphorylation of the lipid flippase activator, Fpk1, by Ypk1 downregulates the Dnf1 and
Dnf2 flippases (142). In addition, Fpk1 has been linked to elevated levels of ROS that are
produced upon loss of Ypk1 (154). Our results do not indicate a connection between Plb1 activity
and Fpk1, as a fpk1∆ strain does not display increased PC turnover and Plb1 does not have a Fpk1/2
phosphoacceptor site. We also discovered that the calcineurin dependent responsive element
(CDRE) transcription factor, Crz1, is a key regulator of the increased PLB1 expression observed
upon disruption of sphingolipid biosynthesis. Interestingly, Crz1 is not responsible for increased
PLB1 transcription observed upon heat stress (Figure 4-7A), suggesting multiple levels of PLB1
regulation, depending on the applied stress. Consistent with our findings, a ypk1∆ykr2∆ strain
bearing a YPK1as allele displays increased expression of several genes, many that have Crz1
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binding sites in their promoters, including PLB1 (151). Based on these and other data, a model
was proposed in which the TORC2 and calcineurin pathways act antagonistically to maintain the
optimal cell growth and survival (151). When Ypk1 is recruited to the plasma membrane by
Slm1/2, there is a shift toward downregulation of the calcineurin pathway and upregulation of
TORC2 signaling. Therefore, in a ypk1∆ strain, activation of the calcineurin pathway would
predominate, activating the downstream transcription factor, Crz1, which in turn activates various
CDRE genes, including PLB1 (Figure 4-10). Interestingly, treatment of cells with myriocin results
in TORC2-dependent phosphorylation of Ypk1 in a manner that requires the Ypk1 recruiting
proteins, Slm1/2, to translocate from eisosomes to membrane compartments containing TOR
(152,153). Since Slm1 relocalization was suggested to be a result of an altered sphingolipid
environment, and an increase in ROS (154), it is tempting to speculate that alterations in the
eisosome lipid environment due to Plb1-mediated PC turnover may also contribute to Slm1
relocalization.
Our phenotypic analysis of the ypk1∆plb1∆ double mutant suggests that upregulated Plb1
activity upon loss of Ypk1 is a functionally important compensatory mechanism, since slowed
growth and sensitivity to calcofluor white are exacerbated upon deletion of PLB1 in the ypk1∆
strain (Figure 4-9). Two lines of evidence indicate Plb1 activity, as opposed to activity of the other
PLBs, mediates this phenomenon: i) only overexpression of PLB1 rescues growth of the
ypk1tsykr2∆ strain at restrictive temperature (Figure 4-8), and ii) turnover of PI, the primary
substrate of Plb3, is not altered in the ypk1∆ strain.
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Figure 4-10. Model of PLB1 transcriptional activation upon loss of Ypk1 or upon
disruption to sphingolipid biosynthesis by the presence of myriocin.
The left panel displays events occurring in a WT cell where the TORC2/Ypk1 signaling pathway
predominates resulting in a basal level of PLB1 trnscription and basal level of Plb1-mediated PC turnover.
The right panel displays event occurring upon loss of YPK1 where the Calcinuerin signaling pathway
predominates causing Crz1 dephosphorylation and resultant elevation of PLB1 trnscript levels and elevation
of Plb1-mediated PC turnover. The right panel (gray) also displays elevation of Crz1 activated PLB1
transcription in the presence of myriocin. The dotted line indicates movement TORC2, Target or
rapamyacin complex 2; SPT, serine palmitoyl transferase.

In summary, our results indicate that Ypk1, in addition to regulating sphingolipid synthesis
and plasma membrane flippase activity, also regulates the turnover of the major phospholipid, PC.
Future studies will focus on the mechanism by which altered sphingolipid biosynthesis, as
engendered by loss of Ypk1, activates the myriad of genes under the control of Crz1, such as Plb1.
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Chapter 5 Summary and Future
Directions
5.1 Summary of results
My dissertation work has resulted in novel contributions to our understanding of the Btype phospholipases in S. cerevisiae. First, Ira1 and Ira2 were implicated in regulation of both the
production of extracellular GroPIns and its transport into the cell. However, I was unable to
implicate the Ras/cAMP pathway in this regulation suggesting that other undefined functions of
Ira1/2 might be involved. Second, examination of various aspects of the GDTR pathway revealed
loss of the cell surface associated PLBs, Plb1-3, and/or utilization of GroPIns as a phosphate source
results in abnormal actin cytoskeleton and an increased cell size. Regarding the reutilization aspect
of the GDTR pathway, I was unable to determine if reacylation of GroPIns can occur in the cell.
Third, I identified a novel interaction between Ypk1 and Plb1 demonstrating that in addition to
regulating sphingolipid synthesis and plasma membrane flippase activity, Ypk1 also regulates the
Plb1-mediated turnover of the major phospholipid, PC.
Additionally, my work has suggested many new avenues that could be pursued in order to
better understand the relationship between phospholipid turnover via phospholipases of the Btype, sphingolipid metabolism, and the Ypk1 kinase. Here, I discuss what I feel are the most
pressing open questions and future directions that could be pursued.
5.2 How does alteration in sphingolipid biosynthesis result in activation of Crz1?
I have documented a novel role for Ypk1 in regulation of Plb1-mediated PC turnover. This
data adds to the published findings indicating that Ypk1 contributes to the maintenance of both
sphingolipid and phospholipid homeostasis. Ypk1 does not appear to regulate Plb1 by direct kinase
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activity, but instead Plb1 activity is elevated in ypk1∆ yeast due to the disruption of sphingolipid
metabolism (Figure 4-5, Figure 4-6). This disruption causes transcriptional upregulation of PLB1
in a Crz1-dependent manner.
To identify genes involved in Crz1-mediated gene regulation, a screen of selected deletion
mutants bearing a plasmid (CDRE plasmid) containing a promoter region with binding sites for
the transcription factor Crz1 linked to the lacZ gene could be utilized. This plasmid has been
constructed by other researchers and is available (11). Transcriptional induction could be
monitored by measuring β-galactosidase activity upon treatment of the cells with myriocin or
another drug disrupting sphingolipid metabolism. Mutants to be tested would include those that
have a link to calcium metabolism, since Crz1 is a calcineurin/calcium-activated transcription
factor. For example, strains lacking the plasma membrane calcium channel complex, Mid1/Cch1,
and the vacuole cation channel Yvc1, both of which allow calcium into the cytoplasm, are prime
candidates to be tested (192).
5.3 Are other genes in phospholipid synthesis affected by disrupted sphingolipid synthesis?
Since Ypk1 appears to be a major regulator of lipid homeostasis, additional genes
transcriptionally regulated by loss of Ypk1 and/or disruptions to sphingolipid biosynthesis could
be identified. Genes of interest may include genes containing potential Crz1 binding sites in their
promoters or genes involved in some aspect of lipid metabolism that I believe are linked to Ypk1
function. Several genes of interest involved in lipid metabolism that also have Crz1 binding sites
in their promoter regions include: ORM2, SCS2, CHO2, NTE1, INO1, OPI3, and LAC1
(YEASTRACT), while other genes of interest involved in lipid metabolism include SPO14 and
GDE1. Specifically, measuring message levels by qRT-PCR of the selected genes could be
performed in two sets of samples: i) in a wild type strain as compared to a ypk1∆ mutant and ii) in
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wild type cells either treated or not treated with the sphingolipid synthesis inhibiting drug,
myriocin.
5.4 Does Plb1 play a role in Slm1 relocalization from eisosomes to MCT domains leading to
TORC2 and Ypk1 activation?
As discussed in Chapter 4, the antagonism between the TORC2 (promotes cell growth) and
the calcineurin (promotes cell survival) pathways suggests a potential explanation for the increase
in Plb1-mediated turnover upon loss of Ypk1 (151,152,193), with cell survival and Crz1 activation
predominating in the absence of Ypk1. The Slm proteins must be translocated from eisosomes to
the plasma membrane MCT in order for Ypk1 to be recruited to the plasma membrane for
activation by TORC2 (153). Recent literature suggests that elevated levels of ROS are the essential
signal for Slm1 relocalization to the MCT (154), and others have demonstrated that depletion of
sphingolipids, hypo-osmotic stress, and mechanical membrane stress all cause Slm1 relocalization
from eisosomes to MCT patches (152). While it has been suggested that sphingolipid levels may
be important for Slm1 movement, it would be interesting to see if Plb1 and PC levels also play a
role. For these experiments localization of fluorescently tagged Slm proteins could be compared
in a WT and plb1∆ strains with and without myriocin treatment. Ypk1 phosphorylation by TORC2
could also be monitored in these strains. If Slm protein localization is altered in plb1∆ cells, ROS
levels could be compared in WT, ypk1∆, plb1∆, and ypk1∆plb1∆ strains since ROS is the proposed
essential mediator of Slm protein relocalization. Fluorescently tagged Slm constructs are available
from other labs (153), and published procedures exist for measuring Ypk1 phosphorylation (153)
and ROS abundance (154). Further understanding of how lipids regulate the Slm proteins and the
resultant Ypk1 activation by TORC2 is of interest because both TORC2 and ROS are elevated in
cancer cells (154).
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5.5 Is the plasma membrane lipid composition altered in YPK1/PLB1 deficient cells?
Evaluation of the plasma membrane phospholipid composition in the YPK1/PLB1 mutants
should be completed to better understand if phospholipid composition itself, in addition to
sphingolipids, may influence Ypk1 signaling and/or cellular processes. Lipid composition
specifically in the plasma membrane, ER, and vacuole fractions of WT, ypk1∆, plb1∆, and
ypk1∆plb1∆ strains could be compared. Each membrane fraction can be isolated by published
techniques and lipids – phospholipids, sphingolipids, neutral lipids, and sterols – can be extracted
and their abundances quantified. Particular lipid composition has been found to be essential for
some plasma membrane enzymes (194,195). Turnover events, through the action of the B-type
phospholipases and other enzymes continually causes alterations to the plasma membrane lipid
composition and is equally important. While my data indicates that PC turnover is altered in the
ypk1∆and

ypk1∆plb1∆

strains,

turnover

of

the

other

major

glycerophospholipids,

phosphatidylinositol (PI), phosphatidylserine (PS), and phosphatidylethanolamine (PE) and the
concomitant production of their metabolites, GroPIns, GroPSer, and GroPEtn could be thoroughly
analyzed. Furthermore, more rigorous evaluation of methylation pathway synthesized PC turnover
is also warranted.
5.6 Is the functionality of model plasma membrane proteins, 1,3-β-glucan synthase, Git1,
Pma1, and Can1, altered in YPK1/PLB1 deficient cells?
Disrupted lipid regulation occurring upon YPK1 deletion may in turn abolish the proper
lipid environment required for activity of essential plasma membrane enzymes. Phospholipase
activity has been shown to alter plasma membrane enzyme function including lysophospholipase
overexpression dependent inhibition of amiloride-sensitive epithelial sodium channel (ENaC)
activity in mammalian cells (196), or PLA2 activity and lysophospholipid inhibition of the 1,3-βglucan synthase in yeast (197). My preliminary experiments have identified several potential
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enzymes whose activities are altered upon deletion of PLB1 and YPK1, including 1,3-β-glucan
synthase (Appendix A 17), Git1 (plasma membrane GPI transporter protein) (Appendix A 19), and
Pma1 (plasma membrane ATPase) (Appendix A 20), and an enzyme whose activity is not altered,
Can1 (arginine transporter) (Appendix A 21).
Additional enzymes of interest, particularly spanning localization in different membrane
compartments could be identified and analyzed for altered function. Upon verification that enzyme
activity is indeed altered, the level of control causing the alterations in enzyme activity could be
determined: transcription (mRNA levels), post-transcriptional (protein levels), activity, and/or
localization. These protein activities could be expected to be involved in phenotypes reported in
this dissertation. Furthermore, if these proteins or others are verified to have altered activity upon
loss of YPK1 and/or PLB1, future studies could evaluate the requirement for specific lipid
environments for their optimal functionality by employing synthetic liposomes.
5.7 Do the B-type phospholipases play a role in deacylation of the phosphorylated
phosphoinositides in vivo?
The roles of the PIPs have been extensively studied in yeast and higher eukaryotes
demonstrating their key regulatory role in fundamental eukaryotic cell processes such as
endo/exocytois, membrane trafficking, cell division, actin organization, and in the localization of
proteins that bind to lipids, such as those with PH domains (31). PIP catabolism mostly occurs
through the action of PLCs, but it can also occur by the action of PLA2 and/or PLB enzymes with
concomitant production of the GroPIPs, lysophospholipids, and free fatty acids, with the GroPIPs
being the least studied metabolite (51). Glucose addition to stationary phase S. cerevisiae cultures
was shown to result in release of GroPIns, GroPI[4]P, and GroPI[4,5]P2 into the extracellular
medium (59). It is known that deacylation reactions are one method of PIP turnover in yeast (45).
In addition, the literature suggests that both PIPs and their deacylation products, the GroPIPs, play
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a role in actin cytoskeleton function. Thus, the potential role of the PLBs in this process is obvious
considering my work showing that strains with PLB1-3 deleted have an increased sensitivity to the
actin destabilizer, Lat A, as well as have an abnormal actin organization in the presence of
Latrunculin A. Examination of PLB activity on the PIPs is also warranted for their potential role
in the Ypk1-Plb1 signaling interaction as the Slm proteins have PH domains that are required for
Ypk1 recruitment to the plasma membrane. Thus, I propose that determining if the PLBs are active
against the PIPs in vivo is warranted.
Although reproducible detection of the GroPIPs has proven difficult since they are
physiologically present at low concentrations, new techniques and dyes specific to PIPs may aid
in future PIP/GroPIP analyses. HPLC or LC/MS analysis of GroPIns and the GroPIPs would need
to be employed. Fusion of known PIP binding domains to specific flares tagged with GFP have
been constructed to use in detection of PtdIns[4,5]P2 and PtdIns[4]P (198,199) and Annexin V
conjugated to Alexa Fluor 488 is available for specific binding to PS (200). Complete analysis of
the PIPs and GroPIPs in the YPK1 and PLB1-3 mutant strains would require development and
optimization of additional techniques to monitor these metabolites at their physiologically relevant
concentrations in vivo.
5.8 Final conclusions about the importance of PLBs
The experiments completed thus far provide novel insights into the roles and regulation of
the B-type phospholipases, and how regulation of lipid metabolism and turnover can affect many
cellular processes. Long-term goals could include further elucidating the mechanism by which
Ypk1 regulates Plb1, and developing an understanding of how this regulation impacts global
cellular processes such as, cell wall integrity, actin dynamics, eisosome assembly, endocytosis,
and general cell health. The outcomes of the studies would further our understanding of how lipid
metabolism is integrated with other important aspects of cellular physiology in a eukaryotic cell.
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Appendix A
Preliminary data from exploratory experiments pertaining to or referenced in Chapter 3 are
found in Appendices A 2 - A 5. Appendices A 6 - A 16 contain data collected as part of the project
described in Chapter 4, but were not included with the submitted manuscript. No narrative will be
included with those figures. Additional preliminary experiments performed by me that were not
pursued further, or that will be continued by other members of the lab are included in Appendices
A 17 - A 21 and are referred to in Chapter 5 for discussion purposes.
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A 1. Genes with predicted or observed phospholipase activity in S. cerevisiae.
(Gene descriptions from SGD, yeastgenome.org)
GeneID

853007

856001

GENE

CLD1

FMP30

Aliases

YGR110W

Description from Saccharomyces Genome Database
Mitochondrial cardiolipin-specific phospholipase; functions upstream of Taz1p to generate
monolyso-cardiolipin; transcription increases upon genotoxic stress; involved in restricting Ty1
transposition; has homology to mammalian CGI-58

YPL103C

Protein with a role in maintaining mitochondrial morphology; also involved in maintaining normal
cardiolipin levels; mitochondrial inner membrane protein; proposed to be involved in Nacylethanolamine metabolism; related to mammalian N-acylPE-specific phospholipase D

856739

ISC1

YER019W

854251

LPX1

YOR084W

854943

NTE1

YML059C

850411

PER1

YCR044C,
COS16

855895

PGC1

YPL206C

855020

PLB1

YMR008C

855018

PLB2

YMR006C

854151

PLB3

YOL011W

855860

PLC1

YPL268W

855720

SPO1

YNL012W

Inositol phosphosphingolipid phospholipase C; mitochondrial membrane localized; hydrolyzes
complex sphingolipids to produce ceramide; activates genes required for non-fermentable carbon
source metabolism during the diauxic shift; activated by phosphatidylserine, cardiolipin, and
phosphatidylglycerol; mediates Na+ and Li+ halotolerance
Peroxisomal matrix-localized lipase; required for normal peroxisome morphology; contains a
peroxisomal targeting signal type 1 (PTS1) and a lipase motif; peroxisomal import requires the
PTS1 receptor, Pex5p and self-interaction; transcriptionally activated by Yrm1p along with genes
involved in multidrug resistance; oleic acid inducible
Serine esterase, phospholipase B; homolog of human neuropathy target esterase (NTE); Nte1pmediated phosphatidylcholine turnover influences transcription factor Opi1p localization,
affecting transcriptional regulation of phospholipid biosynthesis genes
Protein of the endoplasmic reticulum; required for GPI-phospholipase A2 activity that remodels
the GPI anchor as a prerequisite for association of GPI-anchored proteins with lipid rafts;
functionally complemented by human ortholog PERLD1
Phosphatidyl Glycerol phospholipase C; regulates the phosphatidylglycerol (PG) content via a
phospholipase C-type degradation mechanism; contains glycerophosphodiester
phosphodiesterase motifs
Phospholipase B (lysophospholipase) involved in lipid metabolism; required for efficient acyl
chain remodeling of newly synthesized phosphatidylethanolamine-derived phosphatidylcholine;
required for deacylation of phosphatidylcholine and phosphatidylethanolamine but not
phosphatidylinositol; PLB1 has a paralog, PLB3, that arose from the whole genome duplication
Phospholipase B (lysophospholipase) involved in lipid metabolism; displays transacylase activity
in vitro; overproduction confers resistance to lysophosphatidylcholine
Phospholipase B (lysophospholipase) involved in lipid metabolism; hydrolyzes
phosphatidylinositol and phosphatidylserine and displays transacylase activity in vitro; PLB3
has a paralog, PLB1, that arose from the whole genome duplication
Phospholipase C; hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2) to generate the
signaling molecules inositol 1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG); involved in
regulating many cellular processes; Plc1p and inositol polyphosphates are required for acetylCoA homeostasis which regulates global histone acetylation
Meiosis-specific prospore protein; required for meiotic spindle pole body duplication and
separation; required to produce bending force necessary for proper prospore membrane assembly
during sporulation; has similarity to phospholipase B

853902

SPO14

YKR031C,
PLD1

853964

TGL4

YKR089C,
STC1

853309

YJL132W

YJL132W

850809

YLR118C

YLR118C,
APT1

Phospholipase D; catalyzes the hydrolysis of phosphatidylcholine, producing choline and
phosphatidic acid; involved in Sec14p-independent secretion; required for meiosis and spore
formation; differently regulated in secretion and meiosis; participates in transcription initiation
and/or early elongation of specific genes; interacts with "foot domain" of RNA polymerase II;
deletion results in abnormal CTD-Ser5 phosphorylation of RNA polymerase II at specific
promoter regions
Multifunctional lipase/hydrolase/phospholipase; triacylglycerol lipase, steryl ester hydrolase,
and Ca2+-independent phospholipase A2; catalyzes acyl-CoA dependent acylation of LPA to
PA; required with Tgl3p for timely bud formation; phosphorylated and activated by Cdc28p;
TGL4 has a paralog, TGL5, that arose from the whole genome duplication
Putative protein of unknown function; localizes to the membrane fraction; possible Zap1pregulated target gene induced by zinc deficiency; YJL132W is a non-essential gene; contains
domain for Zinc dependent phospholipase C
Acyl-protein thioesterase responsible for depalmitoylation of Gpa1p; green fluorescent protein
(GFP)-fusion protein localizes to both the cytoplasm and nucleus and is induced in response to
the DNA-damaging agent MMS ; contains conserved domain for Abhydrolase 2,
Phospholipase/Carboxylesterase

854187

YOR022C

YOR022C

Putative carboxylic ester hydrolase; similar to bovine phospholipase A1; the authentic, nontagged protein is detected in highly purified mitochondria in high-throughput studies
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A 2. Loss of the cell surface associated PLBs results in invaginations of the cell membrane
when grown in media containing GroPIns as the sole phosphate source.
A, WT (JPV 13) and plb123∆ (JPV 480) were grown on YNB I+ LoPi and YNB I+ NoPi +200 µM GroPIns
agar plates. A sample of the cells from each condition were analyzed by SEM. B, Magnified image of
plb123∆ in GroPIns media Arrows point to cells displaying large invaginations. Photos courtesy of Dr.
Donna Stolz, University of Pittsburgh.

123

A 3. Exposure to LatA alters distribution of actin patches and cables upon loss of PLB1-3.
Cells grown as described in Fig. 3-14. TRITC-phalloidin staining of the actin cytoskeleton in the absence
(A) and presence (B) of Latrunculin A (LatA). Visualized by the Zeiss Axio Observer Z1 confocal
microscope, 100x 1.4NA objective. Images obtained with HCImage software.
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A 4. Alterations in PLB message levels in log phase compared to stationary phase.
Total RNA was extracted from harvested cells followed by DNase treatment. Transcript levels were
analyzed by real-time RT-PCR using the comparative ∆∆CT method. Data were normalized to the amount
of the endogenous control mRNA, SNR17, and expressed relative to the value in WT cells in log phase.
Values represent the mean ± S.E. of at least 3 individual cultures each assayed in triplicate.

A 5. Deletion of LGE1 and PLB3 results in slowed growth and decreased colony size.
WT (JPV 399), plb3∆, lge1∆ (JPV 637), and lge1∆plb3∆ patched to single colonies on YPD plates at 30ºC
(A) and growth curve in YPD media at 30ºC (B). In the lower panels (A), two independent isolates are
streaked from single colonies.
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A 6. Protein Architecture upon construction of the PLB1-I-3HA allele.
(Supplement to Experimental Procedures, HA-allele). The HA tag was inserted into the PLB1 gene without
interference with the localization signal, the GPI signal, and the catalytic site.
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A 7. Plb1 mediated external glycerophosphocholine production is increased upon deletion
of YPK1 at multiple time points in the BY4742 background.
(Supplement to Fig. 4.1A and Table 4.1A). Separation of metabolites from external, internal, and membrane
fractions is shown for multiple time points, after 0, 2, 4, and 13 hours of chase. Values are the means ± S.E.
of at least triplicate cultures.

127

A 8. Plb1 mediated external glycerophosphocholine production is increased upon deletion
of YPK1 at multiple time points in the YPH499 background.
(Supplement to Fig. 4.1B and Table 4.1B). Separation of metabolites from external, internal, and membrane
fractions is shown for multiple time points, after 0, 4, and 8.5 hours of chase. Values are the means ± S.E.
of at least triplicate cultures.
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A 9. Kennedy pathway synthesis of phosphatidylcholine is not altered upon loss of Ypk1.
(Supplement to Fig. 4.3). Strains in the YPH499 background were grown to log phase in YNB 75 µM
inositol media. [C14]-choline was added to equivalent amounts of cells in YNB media and the amount of
incorporation into PC after 30 minutes was determined. Lipids were extracted and [C14]-choline
incorporation was measured by LSC (A) and verified to be incorporated into PC by TLC (B). A nonradioactively labeled standard for PC was visualized by staining the TLC plate with Thioflavin S solution.
Values are the means ± S.E. of three independent cultures assayed in duplicate.

A 10. Deletion of the flippase activators, Fpk1 or Fpk2, or deletion of LSP1 or PIL1,
involved in eisosome formation do not alter extracellular GroPCho production.
(Supplement to Chapter 4). Strains in the BY4742 background bearing the indicated gene deletions were
pre-grown at 30⁰C in YNB media containing 0.2µCi/mL [14C]-Choline chloride, followed by a chase in
YNB media containing 10 mM choline at 37⁰C. Extracellular, intracellular, and membrane fractions were
separated from harvested cells at the listed time points. Separation of [14C]-choline containing metabolites
from extracellular and intracellular fractions was performed using anion exchange column chromatography,
but no differences from WT were observed, except in the ypk1∆ strain as previously discussed. Data shown
is the mean ± S.E. of at least duplicate cultures.

129

A 11. Overexpression of the plasma membrane flippase, DNF1, does not result in altered
extracellular GroPCho production.
Supplement to Chapter 4. WT (BY4742) was transformed with pRS423 (JVE 338) and pRS423-DNF1
(JVE 339) and pre-grown at 30⁰C in YNB media lacking uracil containing 0.2µCi/mL [14C]-Choline
chloride, followed by a chase in YNB media containing 10mM choline at 37⁰C. Extracellular, intracellular,
and membrane fractions were separated from harvested cells at the listed time points. Separation of [ 14C]choline containing metabolites from extracellular and intracellular fractions was performed using anion
exchange column chromatography. Data shown is the mean ± S.E. of triplicate transformants.
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A 12. Secreted and cell-surface associated Plb1 protein abundance in log and stationary
phase is elevated in a ypk1∆ mutant.
(Supplement to Figure 4-4). A, WT + PLB1-I-3xHA and ypk1∆ + PLB1-I-3xHA were grown in YNB media
at 30⁰C to log and stationary phase. Supernatant was concentrated 100-fold, while total protein was
extracted from the cells. Western blot was performed on all fractions using an anti-HA-Plb1 primary
antibody and HRP-conjugated anti-mouse secondary. Note there is less protein in the stationary phase
samples than the log phase samples.

A 13. Regulation of PLB1, PLB2, and PLB3 message levels upon loss of Ypk1 or upon loss
of transcription factors, Crz1, Msn2, and Msn4.
Strains in the BY4742 background were grown to early log phase in YNB media at 30°C. Total RNA was
extracted and PLB transcript levels were analyzed by qRT-PCR using the comparative ∆∆CT method. Data
were normalized to the amount of the endogenous control mRNA, SNR17, and expressed relative to the
value in WT cells. Values represent the mean ± S.E. of three cultures assayed in triplicate. Results of interest
from this experiment include upregulation of PLB3 in ypk1 cells compared to WT, however a concurrent
increase in Plb3-mediated GroPIns production was not observed (Chapter 4). Msn2 and Msn4 did not
appear to regulate PLB1 or PLB3 under the growth conditions tested, but may be involved in depressing
PLB2 message. Crz1 appears to have regulate PLB1 and possibly PLB3 message levels.
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A 14. Compromised sphingolipid synthesis by the presence of myriocin results in increased
extracellular GroPCho production.
(Supplemental to Fig. 5E.) Separation of metabolites from external, internal, and membrane fractions is
shown for multiple time points, after 0, 3, and 6 hours of chase. Values are the means ± S.E. of at least
triplicate cultures.
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A 15. Overexpression of the PLB genes on a multicopy plasmid elevates corresponding PLB
message levels.
(Supplemental to Figure 4-8). A, WT cells transformed with the PLB overexpression plasmids, YEp351PLB1, YEp351-PLB2, YEp351-PLB3, and pRS426-NTE1, were grown to log phase in selective media at
30°C. Total RNA was extracted and PLB1, PLB2, PLB3, and NTE1 transcript levels were analyzed by realtime qRT-PCR using the comparative ∆∆CT method. Message levels were normalized to the endogenous
control, SNR17, and expressed relative to the message in corresponding WT + empty vector. Values
represent the mean ± S.E. of at least 3 individual transformants assayed in triplicate. 2-way ANOVA
showed no statistical difference between values for PLB1, PLB2, or PLB3, but expression of NTE1 was
significantly different.

A 16. The slowed growth phenotype and sensitivity to the cell wall perturbing agent,
calcofluor white, for a ypk1∆ strain is exacerbated by deletion of PLB1.
(Supplemental to Figure 4-9). Strains in the YPH499 (A and B) and BY4742 (C and D) backgrounds were
grown in YNB media containing 75 µM inositol at 30⁰C and 37⁰C. Data represent the mean and standard
error of at least three replicates. E, Cells from 10-fold serial dilutions of strains in the YPH499 background
were spotted onto YPD, YPD + 0.5 M NaCl, and YPD + 8.5 µg/mL calcofluor white plates and incubated
at both 30⁰C and 35⁰C for 3 days. None of the strains were able to grow on YPD + 8.5 µg/mL calcofluor
white plates at 35⁰C. Data displayed is representative of multiple experiments.
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A 17. 1,3-β glucan synthase activity is depressed upon deletion of PLB1 and YPK1.
Plasma membrane isolated from WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV
669) grown in YNB I+ media to log phase (OD600 ≈ 0.7) at 30C, harvested, washed with 1 mM EDTA, and
assayed for 1,3-β-glucan synthase activity according to published procedures (201-203). Acid washed glass
beads (2 mL) and 8 mL of cold Breaking Solution (0.5 M NaCl, 1 mM EDTA, 1 mM PMSF) were added
to cell pellet on ice. Vortex and incubations on ice were done alternately for 1-2 minutes and repeated 10
times. Cell lysate was transferred to a fresh tube and beads were washed with an aliquot of breaking buffer
and added to the lysate. Centrifuging 5 minutes at 1500 x g at 4⁰C cleared unbroken cell and debris.
Supernatant (membrane fraction) was transferred to ultracentrifuge tubes and breaking solution was added
up to top of tube. Membranes were pelleted at 100,000 x g for 30 minutes at 4⁰C. Pellet was resuspended
in 1mL of membrane buffer (50 mM Tris-HCl pH = 7.5, 1 mM EDTA, 1 mM β-mercaptoethanol, 33%
glycerol) and homogenized on ice with the Dounce homogenizer. Protein concentration was determined by
Bradford assay. 20µg of protein was assayed for 1 hour at 30°C in a reaction containing 2 µL of 0.1 M
UDP-glucose, 1.25 µL of UDP-[14C]-glucose (0.02 µCi/mL), 3 µL of 10% BSA, 2 µL of 0.5 M KF, 3 µL
of 10mM EDTA, 4µL of 1mM GTP, and water up to 40µL. The reaction was stopped by addition of 1mL
10% TCA and filtered through glass fiber (GF/C, Whatman 1822-025). Filters were washed with three 1
mL aliquots of 10% TCA followed by two 1 mL washes with 95% ethanol. Incorporation of [C14]-UDPglucose into cells was quantified by liquid scintillation counting. Data represent mean ± S.E. of four
independent cultures. The ypk1plb1 1,3-β-glucan synthase activity is from multiple colonies of only one
deletion isolate.
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A 18. Altered expression of the catalytic subunit of 1,3-β glucan synthase, Fks2.
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) transformed with pFKS2lacZ (JVE 336) were grown to log phase (OD600 ≈ 0.8) in YNB –URA media at 30ºC and 37ºC. Harvested
cells were assayed for β-gal activity as described in Experimental Procedures (Chapter 2.3.1). Data
represent the mean ± S.E. of four independent transformants.

A 19. Activity of the plasma membrane protein, Git1, is depressed upon loss of Ypk1
and/or Plb1.
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) grown in YNB I- 200µM
KH2PO4 media were harvested and assayed for their ability to transport [H3]-GroPIns in a 6 minute assay
at 30ºC as described in Materials and Methods (Chapter 2). Data represent the mean ± S.E. of three
independent cultures assayed in duplicate.
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A 20. Pma1 activity is not lost by deletion of PLB1 and/or YPK1.
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) cells grown in YNB I+
media to log phase at 30ºC were harvested and membranes isolated as described in Galan et al.(204).
Sodium azide was added to culture, cells were pelleted and washed, and resuspended in lysis buffer (0.1 M
Tris-HCl pH = 7.5, 0.15 M NaCl, 5 mM EDTA, protease inhibitor mix) to a concentration of 50 ODU/0.2
mL. Chilled glass beads were added to meniscus of suspension and vigorously agitated with a vortex
between incubations on ice. Lysate was removed to a fresh tube and beads were washed with aliquot of
lysis buffer that was added to cell lysate. Centrifugation at 3,000 rpm (should have been slower because
likely lost Pma1 at this speed) removed unbroken cells and debris. Supernatant was removed as the PM
enriched fraction and centrifuged for 45 minutes at 12,000 rpm x g. Pellet containing membranes was
resuspended in 10X diluted lysis buffer. Protein concentration was measure by Bradford assay. 40 µg of
protein was assayed for ATPase activity as described in Koland et al.(205). Protein sample was added to 1
mL of ATPase assay buffer (50 mM MES, 5 mM MgCl2, 5 mM NaN3, pH = 6 with Tris) with and without
100 µM orthovanadate and pre-incubated for 5 minutes at 30ºC. To start assay 20 µL of 0.1 M ATP (sodium
salt) was added and incubated for 10 minutes at 30ºC. The reaction was stopped with 2mL of stop solution
(2% sulfuric acid, 0.5% ammonium molybdate, 0.5% SDS). The product corresponding to ATPase activity,
phosphomolybdate, was reduced by addition of 20 uL of 10% ascorbic acid. The reaction sat for 5minutes
at RT before absorbance was read at 750 nm. Blanks containing no enzyme and no ATP were run to subtract
out background. Data trends are representative multiple experiments.
- Arginine
plb1∆

WT

ypk1∆plb1∆

ypk1∆

can1∆

WT

- Arginine + Canavanine

A 21. Sensitivity to canavanine is not altered upon YPK1 and/or PLB1 deletion.
Indicates Can1 arginine transport is not compromised in these strains. WT (JPV 399), plb1 (JPV 668),
ypk1 (JPV 636), ypk1plb1 (JPV 669), WT (JPV 523), ypk1 (JPV 768), ypk1tsykr2 (JPV 771) and
can1 cells were grown in YNB media, diluted to OD600 = 1.0 in water. Four 10-fold serial dilutions were
performed and 5 µL of each dilution was spotted onto YNB – arginine plates ± 7.5 µg/mL canavanine.
Plates were incubated at 30ºC and 37ºC for 48 hours.
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